≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Erythema nodosum

DOID EFO Endpoint Browser PheWeb

L12_ERYTHEMANODOSUM

erythema infectiosum: usually a benign childhood condition characterized by a classic slapped-cheek appearance (see the image below) and lacy exanthem.It results from infection with human parvovirus (PV) B19, an erythrovirus.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L52
  • Hospital discharge: ICD-9 — 6952
  • Hospital discharge: ICD-8 — 69520
  • Cause of death: ICD-10 — L52
  • Cause of death: ICD-9 — 6952
  • Cause of death: ICD-8 — 69520

2 out of 7 registries used, show all original rules.

1182

4. Check minimum number of events

None

1182

5. Include endpoints

None

1182

6. Filter based on genotype QC (FinnGen only)

1140

Control definitions (FinnGen only)

Control exclude
L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L50-L54
Name in latin
Erythema nodosum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9004 6843 2116
Only index persons 7799 5941 1858
Unadjusted period prevalence (%)
Whole population 0.16 0.20 0.06
Only index persons 0.18 0.22 0.07
Median age at first event (years)
Whole population 40.55 41.91 36.01
Only index persons 37.81 38.86 34.46

-FinnGen-

Key figures

All Female Male
Number of individuals 1140 903 237
Unadjusted period prevalence (%) 0.28 0.32 0.11
Median age at first event (years) 39.33 38.87 41.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1182
Matched controls
11820
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L52
ICD-10 Finland
Erythema nodosum
1133.5
307.7
716
16
69520
ICD-8 Finland
Erythematous condition, Erythema nodosum
+∞
293.3
269
*
6952A
ICD-9 Finland
Erythematous conditions, Erythema nodosum[ERYTHEMA NODOSUM ACUTUM]
+∞
111.2
105
*
M79.3
ICD-10 Finland
Panniculitis, unspecified
56.5
95.2
54
10
M148, L529,
ICD-10 Finland
+∞
90.8
86
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.5
77.9
215
551
L04AX01
ATC
azathioprine; systemic
6.2
67.8
122
214
D86.0
ICD-10 Finland
Sarcoidosis of lung
12.9
66.3
65
53
H02AB06
ATC
prednisolone; systemic
2.8
65.7
716
4150
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
17.3
63.7
53
32
A46
ICD-10 Finland
Erysipelas
3.2
51.8
248
909
M14.8*L52
ICD-10 Finland
Arthropathy in erythema: nodosum
+∞
43.0
41
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
11.4
40.8
43
39
L529, ,
ICD-10 Finland
+∞
39.8
38
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.4
38.7
102
248
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
34.7
618
4028
A07EC02
ATC
mesalazine; oral, rectal
3.7
31.1
105
305
13597
ICD-8 Finland
Sarcoidosis, Suspecta
42.3
30.1
37
9
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
11.8
29.2
30
26
K50.8
ICD-10 Finland
Other Crohn disease
6.8
29.1
46
70
132
Kela drug reimbursment
Sarcoidosis
11.0
28.8
31
29
R50.9
ICD-10 Finland
Fever, unspecified
2.4
27.4
230
1095
H02AB07
ATC
prednisone; oral
2.4
25.3
201
931
J01FF01
ATC
clindamycin; systemic
2.0
23.7
359
2135
R60.0
ICD-10 Finland
Localized oedema
2.4
23.4
186
860
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
8.3
22.7
30
37
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
4.1
22.7
63
159
K51.5
ICD-10 Finland
Left sided colitis
4.4
22.2
56
131
K50.1
ICD-10 Finland
Crohn disease of large intestine
7.2
22.1
33
47
A02BC02
ATC
pantoprazole; systemic
1.9
21.7
845
6713
TGC00
NOMESCO Finland
Bronchial lavation
4.7
21.6
50
109
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
21.6
172
795
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
21.4
298
1714
J01MA02
ATC
ciprofloxacin; systemic
1.8
21.2
463
3078
M13.9
ICD-10 Finland
Arthritis, unspecified
2.7
21.0
121
480
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
20.2
181
879
UJF32
NOMESCO Finland
Coloscopy
1.9
19.7
328
1995
K50.9
ICD-10 Finland
Crohn disease, unspecified
5.2
19.4
40
79
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
19.3
142
633
L04AA06
ATC
mycophenolic acid; systemic
5.3
19.0
38
73
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.1
18.6
80
270
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
18.4
152
712
D07AC01
ATC
betamethasone; topical
1.8
18.4
449
3055
SPAT1255
SPAT
Intravenous administration of medicine
2.8
18.3
93
345
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
18.2
447
3044
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
3.3
17.9
70
223
E0000UV, ,
ATC
1.7
17.8
531
3811
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
17.7
364
2352
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
7.0
17.0
26
38
TQW80
NOMESCO Finland
Local dermatologic skincare
4.2
16.7
45
111
C03CA01
ATC
furosemide; systemic
1.8
16.6
332
2121
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
16.0
103
431
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.5
15.9
56
167
L04AX03
ATC
methotrexate; systemic
2.2
15.6
141
684
ZX120
NOMESCO Finland
Intravenous
2.3
15.6
130
610
K51.8
ICD-10 Finland
Other ulcerative colitis
5.0
15.5
33
67
M04AA01
ATC
allopurinol; systemic
2.2
15.1
135
652
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
4.3
14.9
39
94
M14.8
ICD-10 Finland
Arthropathies in other specified diseases classified elsewhere
81.1
14.6
16
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
14.3
108
485
H02AB04
ATC
methylprednisolone; systemic
2.0
14.2
180
989
J01DA01
ATC
[U] cefalexin
1.6
14.0
735
5948
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
14.0
264
1646
A07EA06
ATC
budesonide; oral, local oral
3.0
14.0
62
213
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
13.9
84
340
127
Kela drug reimbursment
Transplant complication
5.6
13.9
26
47
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
18.5
13.4
20
11
P01BA02
ATC
hydroxychloroquine; oral
2.2
13.4
120
580
A07EA02
ATC
hydrocortisone; rectal
4.1
13.2
36
90
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
13.0
71
274
H02AB09
ATC
hydrocortisone; systemic
3.6
12.9
42
119
SPAT1263
SPAT
Sampling
1.6
12.9
490
3650
M14.8*D86.8
ICD-10 Finland
Arthropathy in sarcoidosis
70.6
12.6
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.3
12.3
100
464
J01MA12
ATC
levofloxacin; systemic
1.8
12.1
205
1233
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
12.1
73
296
J01DB01
ATC
cefalexin; oral
1.7
11.7
970
8575
L04AA01
ATC
[U] ciclosporin
5.6
11.7
22
40
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.0
11.5
32
81
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
11.0
229
1459
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
11.0
69
285
S97
ICPC
Chronic ulcer skin
2.3
10.8
80
357
L04AB04
ATC
adalimumab; parenteral
3.4
10.7
39
119
D86.3
ICD-10 Finland
Sarcoidosis of skin
18.0
10.7
16
9
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
10.5
140
780
L17
ICPC
Foot/toe symptom/complaint
1.6
10.4
369
2674
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.7
10.3
55
210
13599
ICD-8 Finland
Sarcoidosis, Unspecified
13.2
10.2
17
13
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.7
10.1
32
89
D07AD01
ATC
clobetasol; topical
1.7
10.0
200
1258
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
10.0
269
1828
S01
ICPC
Pain/tenderness of skin
2.5
9.8
63
263
M30.0
ICD-10 Finland
Polyarteritis nodosa
20.2
9.8
14
7
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
9.8
105
543
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
9.7
70
309
S18
ICPC
Laceration/cut
1.5
9.7
531
4203
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.6
436
3320
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
9.6
83
395
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
9.2
9.5
19
21
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
9.3
100
517
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
9.3
139
803
C03DA01
ATC
spironolactone; oral
1.8
9.3
135
774
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
9.2
51
199
SPAT1262
SPAT
Handing over of treatment supplies
1.7
9.2
183
1150
R06.0
ICD-10 Finland
Dyspnoea
1.5
9.1
310
2216
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.7
9.0
28
77
J01AA02
ATC
doxycycline; systemic
1.5
9.0
884
7795
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.1
9.0
37
122
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
9.0
74
345
R03AC02
ATC
salbutamol; inhalant
1.5
9.0
655
5445
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
8.9
60
257
J01DA09
ATC
[U] cefadroxil
1.5
8.9
304
2176
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
4.7
8.8
20
43
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
8.8
267
1859
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
3.6
8.7
28
79
L04AD01
ATC
ciclosporin; systemic
3.8
8.5
25
66
L50.9
ICD-10 Finland
Urticaria, unspecified
3.5
8.5
29
85
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.4
8.5
30
90
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
8.5
199
1302
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.5
458
3587
WZC00, ,
SPAT
1.7
8.4
177
1126
L95.8
ICD-10 Finland
Other vasculitis limited to skin
12.9
8.4
14
11
B01AB05
ATC
enoxaparin; parenteral
1.5
8.2
349
2605
L01BB02
ATC
mercaptopurine; oral
4.4
8.2
20
46
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
8.0
85
438
M79.6
ICD-10 Finland
Pain in limb
1.4
8.0
518
4184
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
7.9
146
896
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.9
475
3780
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
7.8
136
821
D07AC13
ATC
mometasone; topical
1.5
7.8
318
2351
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.7
7.8
41
156
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
7.7
59
267
SPAT1260
SPAT
Consultation of another employee
1.6
7.7
192
1273
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
7.7
45
180
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
7.5
478
3833
D94
ICPC
Chronic enteritis/ulcerative colitis
7.2
7.5
17
24
L01BA01
ATC
methotrexate; systemic
2.5
7.5
46
189
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
7.4
224
1552
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
7.4
136
834
S29
ICPC
Skin symptom/complaint other
1.5
7.4
232
1623
J01FA06
ATC
roxithromycin; oral
1.4
7.4
445
3534
6952C
ICD-9 Finland
Erythematous conditions, Erythema nodosum[VASCULITIS NODULARIS,ERYTHEMA INDURATUM NONTUBERCUL]
+∞
7.3
7
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
7.3
52
229
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.2
136
839
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
15.9
7.2
11
7
A08
ICPC
Swelling
2.0
7.1
71
358
L50.8
ICD-10 Finland
Other urticaria
8.0
7.1
15
19
K51
ICD-10 Finland
Ulcerative colitis
4.1
7.1
19
47
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.5
7.1
44
182
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.0
253
1821
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.4
7.0
24
71
T90
ICPC
Diabetes non-insulin dependent
1.5
7.0
242
1728
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
6.9
144
912
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.4
6.9
44
184
D86
ICD-10 Finland
Sarcoidosis
13.9
6.9
11
8
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
6.9
24
72
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.8
108
636
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
6.8
48
211
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
6.8
44
186
03992
ICD-8 Finland
Other bacterial diseases, Infectio Yersinia (Pasteurella) enterocolitica
40.3
6.8
8
*
R05
ICD-10 Finland
Cough
1.5
6.7
249
1800
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
6.7
105
616
J02AC01
ATC
fluconazole; systemic
1.4
6.7
480
3910
S76
ICPC
Skin infection other
2.1
6.6
63
312
E000001, ,
ATC
1.5
6.6
216
1520
J04BA02
ATC
dapsone; oral
7.9
6.6
14
18
XQ848
NOMESCO Finland
Dermatological photography
2.6
6.6
36
140
M25.5
ICD-10 Finland
Pain in joint
1.4
6.5
392
3096
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
6.5
60
294
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.5
236
1699
B01AB10
ATC
tinzaparin; parenteral
1.7
6.5
126
785
L04AD02
ATC
tacrolimus; systemic
5.7
6.5
17
30
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
4.0
6.5
18
46
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.0
6.5
18
46
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
70.2
6.4
7
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.5
6.4
38
154
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.3
133
845
H15.1
ICD-10 Finland
Episcleritis
3.2
6.3
24
76
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.5
6.2
39
162
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
6.2
43
187
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.1
6.2
14
20
R06AE07
ATC
cetirizine; oral
1.4
6.2
498
4114
SPAT1229
SPAT
Assessment of need for aid
1.9
6.2
78
427
M05BA04
ATC
alendronic acid; oral
1.7
6.2
103
615
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.2
238
1733
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.1
121
758
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
6.1
105
634
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.4
6.0
38
159

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Internal Medicine
11 [38004456]
5.1e-01
7.7e-01
2.3e+00
7.1e+00
2.9e+00
1.4e+00
5.6e-01
cases:25.71%
controls:17.14%
cases:14.38%
controls:7.23%
cases:11.11%
controls:1.18%
cases:41.07%
controls:0.06%
cases:18.19%
controls:1.22%
cases:23.88%
controls:7.03%
cases:27.77%
controls:18.08%
236
1550
682
7491
132
654
786
8387
102
107
816
8934
377
5
541
9036
167
110
751
8921
214
623
682
8245
233
1494
606
6770
Emergency Room Visit
ER [9203]
4.8e-01
7.4e-01
2.5e+00
6.6e+00
2.0e+00
6.8e-01
4.8e-01
cases:36.49%
controls:26.24%
cases:17.54%
controls:9.18%
cases:12.42%
controls:1.14%
cases:29.74%
controls:0.06%
cases:8.61%
controls:1.27%
cases:16.29%
controls:8.96%
cases:36.35%
controls:26.15%
335
2372
583
6669
161
830
757
8211
114
103
804
8938
273
5
645
9036
79
115
839
8916
146
795
750
8073
305
2161
534
6103
azathioprine; oral, parenteral
L04AX01 [21603927]
1.9e+00
2.1e+00
2.9e+00
—
2.0e+00
2.4e+00
2.2e+00
cases:3.16%
controls:0.51%
cases:2.61%
controls:0.34%
cases:1.63%
controls:0.09%
—
—
cases:0.98%
controls:0.13%
cases:3.79%
controls:0.37%
cases:4.17%
controls:0.46%
29
46
889
8995
24
31
894
9010
15
8
903
9033
—
9
12
909
9019
34
33
862
8835
35
38
804
8226
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.2e-01
1.1e+00
1.9e+00
4.3e+00
2.3e+00
1.5e+00
1.0e+00
cases:11.98%
controls:7.47%
cases:12.20%
controls:4.59%
cases:8.28%
controls:1.27%
cases:4.03%
controls:0.06%
cases:10.46%
controls:1.14%
cases:17.19%
controls:4.34%
cases:23.96%
controls:10.36%
110
675
808
8366
112
415
806
8626
76
115
842
8926
37
5
881
9036
96
103
822
8928
154
385
742
8483
201
856
638
7408
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
2.0e+00
3.2e+00
1.0e+50
1.0e+50
1.0e+50
3.9e+00
3.3e+00
cases:1.74%
controls:0.23%
cases:2.07%
controls:0.09%
cases:3.05%
controls:0.00%
cases:1.31%
controls:0.00%
cases:5.66%
controls:0.00%
cases:5.80%
controls:0.12%
cases:5.01%
controls:0.19%
16
21
902
9020
19
8
899
9033
28
0
890
9041
12
0
906
9041
52
0
866
9031
52
11
844
8857
42
16
797
8248
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
8.5e-01
1.2e+00
2.2e+00
1.0e+50
4.2e+00
2.6e+00
1.2e+00
cases:11.44%
controls:5.21%
cases:7.41%
controls:2.28%
cases:4.03%
controls:0.45%
cases:28.98%
controls:0.00%
cases:17.76%
controls:0.33%
cases:23.33%
controls:2.12%
cases:19.43%
controls:6.66%
105
471
813
8570
68
206
850
8835
37
41
881
9000
266
0
652
9041
163
30
755
9001
209
188
687
8680
163
550
676
7714
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
1.4e+00
1.6e+00
3.3e+00
—
2.7e+00
2.0e+00
1.4e+00
cases:1.53%
controls:0.39%
cases:1.85%
controls:0.39%
cases:1.42%
controls:0.06%
—
—
cases:0.98%
controls:0.07%
cases:2.34%
controls:0.33%
cases:4.77%
controls:1.25%
14
35
904
9006
17
35
901
9006
13
5
905
9036
—
9
6
909
9025
21
29
875
8839
40
103
799
8161
Inpatient Hospital
21 [8717]
3.7e-01
4.9e-01
1.9e+00
6.0e+00
2.2e+00
5.9e-01
3.8e-01
cases:36.71%
controls:28.51%
cases:14.71%
controls:9.51%
cases:6.64%
controls:1.11%
cases:23.75%
controls:0.08%
cases:8.93%
controls:1.11%
cases:15.40%
controls:9.19%
cases:32.42%
controls:24.65%
337
2578
581
6463
135
860
783
8181
61
100
857
8941
218
7
700
9034
82
100
836
8931
138
815
758
8053
272
2037
567
6227
Dermatitis, unspecified
L30.9 [45572271]
7.5e-01
1.7e+00
3.5e+00
1.0e+50
3.2e+00
1.8e+00
8.5e-01
cases:2.83%
controls:1.36%
cases:2.72%
controls:0.49%
cases:2.51%
controls:0.08%
cases:1.09%
controls:0.00%
cases:1.31%
controls:0.06%
cases:2.57%
controls:0.42%
cases:5.48%
controls:2.42%
26
123
892
8918
25
44
893
8997
23
7
895
9034
10
0
908
9041
12
5
906
9026
23
37
873
8831
46
200
793
8064
Hematology
82 [38004501]
1.5e+00
1.8e+00
2.4e+00
1.0e+50
2.3e+00
2.3e+00
1.5e+00
cases:2.83%
controls:0.63%
cases:2.18%
controls:0.35%
cases:1.20%
controls:0.11%
cases:0.65%
controls:0.00%
cases:1.20%
controls:0.12%
cases:3.68%
controls:0.38%
cases:3.58%
controls:0.85%
26
57
892
8984
20
32
898
9009
11
10
907
9031
6
0
912
9041
11
11
907
9020
33
34
863
8834
30
70
809
8194
Other Crohn disease
K50.8 [45533599]
1.8e+00
2.0e+00
—
1.0e+50
2.8e+00
2.7e+00
2.5e+00
cases:1.20%
controls:0.20%
cases:1.09%
controls:0.15%
—
—
cases:0.76%
controls:0.00%
cases:0.87%
controls:0.06%
cases:2.01%
controls:0.14%
cases:2.86%
controls:0.23%
11
18
907
9023
10
14
908
9027
—
7
0
911
9041
8
5
910
9026
18
12
878
8856
24
19
815
8245
Rheumatology
66 [38004491]
1.3e+00
1.2e+00
2.5e+00
—
3.1e+00
2.1e+00
1.4e+00
cases:7.30%
controls:2.11%
cases:4.36%
controls:1.31%
cases:2.83%
controls:0.23%
—
—
cases:5.66%
controls:0.27%
cases:10.04%
controls:1.35%
cases:10.37%
controls:2.69%
67
191
851
8850
40
118
878
8923
26
21
892
9020
—
52
24
866
9007
90
120
806
8748
87
222
752
8042
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
1.4e+00
1.4e+00
3.1e+00
—
2.6e+00
1.9e+00
1.3e+00
cases:1.85%
controls:0.49%
cases:1.85%
controls:0.45%
cases:1.42%
controls:0.07%
—
—
cases:0.87%
controls:0.07%
cases:2.46%
controls:0.38%
cases:5.01%
controls:1.36%
17
44
901
8997
17
41
901
9000
13
6
905
9035
—
8
6
910
9025
22
34
874
8834
42
112
797
8152
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.5e+00
2.8e+00
1.0e+50
1.0e+50
—
4.0e+00
3.2e+00
cases:1.85%
controls:0.42%
cases:2.61%
controls:0.17%
cases:3.81%
controls:0.00%
cases:1.63%
controls:0.00%
—
—
cases:7.70%
controls:0.15%
cases:6.91%
controls:0.29%
17
38
901
9003
24
15
894
9026
35
0
883
9041
15
0
903
9041
—
69
13
827
8855
58
24
781
8240
prednisolone
A07EA01 [21600653]
1.0e+00
1.5e+00
2.1e+00
—
3.6e+00
2.0e+00
1.3e+00
cases:16.34%
controls:6.66%
cases:12.31%
controls:3.14%
cases:4.14%
controls:0.54%
—
—
cases:16.45%
controls:0.52%
cases:19.20%
controls:3.07%
cases:24.31%
controls:8.07%
150
602
768
8439
113
284
805
8757
38
49
880
8992
—
151
47
767
8984
172
272
724
8596
204
667
635
7597
prednisolone; oral, parenteral
H02AB06 [21602734]
1.0e+00
1.5e+00
2.1e+00
—
3.6e+00
2.0e+00
1.3e+00
cases:16.23%
controls:6.63%
cases:12.31%
controls:3.14%
cases:4.14%
controls:0.54%
—
—
cases:16.45%
controls:0.52%
cases:19.20%
controls:3.06%
cases:24.20%
controls:8.03%
149
599
769
8442
113
284
805
8757
38
49
880
8992
—
151
47
767
8984
172
271
724
8597
203
664
636
7600
Blasts/Leukocytes in Blood
26446-5 [3025159]
1.2e+00
1.7e+00
3.1e+00
—
2.4e+00
1.7e+00
1.3e+00
cases:1.42%
controls:0.42%
cases:2.07%
controls:0.39%
cases:1.53%
controls:0.07%
—
—
cases:0.98%
controls:0.09%
cases:2.12%
controls:0.41%
cases:4.29%
controls:1.26%
13
38
905
9003
19
35
899
9006
14
6
904
9035
—
9
8
909
9023
19
36
877
8832
36
104
803
8160
prednisone
A07EA03 [21600655]
1.0e+00
1.3e+00
1.8e+00
—
3.9e+00
2.0e+00
1.3e+00
cases:3.16%
controls:1.16%
cases:1.31%
controls:0.37%
cases:0.76%
controls:0.12%
—
—
cases:3.05%
controls:0.07%
cases:2.79%
controls:0.37%
cases:4.17%
controls:1.13%
29
105
889
8936
12
33
906
9008
7
11
911
9030
—
28
6
890
9025
25
33
871
8835
35
93
804
8171
prednisone; oral
H02AB07 [21602735]
1.0e+00
1.3e+00
1.8e+00
—
3.9e+00
2.0e+00
1.3e+00
cases:3.16%
controls:1.16%
cases:1.31%
controls:0.37%
cases:0.76%
controls:0.12%
—
—
cases:3.05%
controls:0.07%
cases:2.79%
controls:0.37%
cases:4.17%
controls:1.13%
29
105
889
8936
12
33
906
9008
7
11
911
9030
—
28
6
890
9025
25
33
871
8835
35
93
804
8171
Infectious Disease
44 [38004484]
8.1e-01
9.1e-01
3.1e+00
1.0e+50
3.9e+00
2.4e+00
1.1e+00
cases:2.51%
controls:1.13%
cases:1.53%
controls:0.62%
cases:1.74%
controls:0.08%
cases:2.51%
controls:0.00%
cases:3.05%
controls:0.07%
cases:4.46%
controls:0.41%
cases:4.41%
controls:1.51%
23
102
895
8939
14
56
904
8985
16
7
902
9034
23
0
895
9041
28
6
890
9025
40
36
856
8832
37
125
802
8139
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.4e-01
8.1e-01
2.2e+00
4.8e+00
2.1e+00
8.6e-01
3.8e-01
cases:19.28%
controls:17.16%
cases:21.79%
controls:11.05%
cases:17.32%
controls:2.18%
cases:13.29%
controls:0.12%
cases:15.80%
controls:2.15%
cases:23.33%
controls:11.45%
cases:33.02%
controls:25.15%
177
1551
741
7490
200
999
718
8042
159
197
759
8844
122
11
796
9030
145
194
773
8837
209
1015
687
7853
277
2078
562
6186
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
1.3e+00
1.4e+00
3.0e+00
—
2.4e+00
1.8e+00
1.3e+00
cases:1.63%
controls:0.46%
cases:1.74%
controls:0.42%
cases:1.31%
controls:0.07%
—
—
cases:0.76%
controls:0.07%
cases:2.12%
controls:0.37%
cases:4.65%
controls:1.33%
15
42
903
8999
16
38
902
9003
12
6
906
9035
—
7
6
911
9025
19
33
877
8835
39
110
800
8154
mesalazine; oral, rectal
A07EC02 [21600664]
1.5e+00
1.6e+00
2.1e+00
—
2.5e+00
1.8e+00
1.6e+00
cases:4.03%
controls:0.91%
cases:3.27%
controls:0.66%
cases:1.85%
controls:0.22%
—
—
cases:2.18%
controls:0.18%
cases:3.79%
controls:0.67%
cases:4.29%
controls:0.92%
37
82
881
8959
30
60
888
8981
17
20
901
9021
—
20
16
898
9015
34
59
862
8809
36
76
803
8188
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.9e-01
8.1e-01
1.9e+00
4.4e+00
2.2e+00
1.1e+00
6.7e-01
cases:13.29%
controls:10.26%
cases:13.83%
controls:6.69%
cases:8.61%
controls:1.35%
cases:4.25%
controls:0.06%
cases:9.15%
controls:1.15%
cases:18.30%
controls:6.78%
cases:26.22%
controls:15.38%
122
928
796
8113
127
605
791
8436
79
122
839
8919
39
5
879
9036
84
104
834
8927
164
601
732
8267
220
1271
619
6993
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.8e-01
7.7e-01
1.9e+00
4.0e+00
2.2e+00
1.0e+00
6.4e-01
cases:7.30%
controls:4.65%
cases:8.50%
controls:4.11%
cases:5.99%
controls:0.91%
cases:2.83%
controls:0.06%
cases:6.86%
controls:0.79%
cases:11.05%
controls:4.29%
cases:15.26%
controls:8.68%
67
420
851
8621
78
372
840
8669
55
82
863
8959
26
5
892
9036
63
71
855
8960
99
380
797
8488
128
717
711
7547
Emergency Medicine
93 [38004510]
3.5e-01
7.6e-01
1.9e+00
5.3e+00
1.5e+00
6.3e-01
3.6e-01
cases:10.24%
controls:7.45%
cases:8.50%
controls:4.16%
cases:3.49%
controls:0.53%
cases:9.91%
controls:0.06%
cases:3.27%
controls:0.72%
cases:7.92%
controls:4.40%
cases:17.76%
controls:13.13%
94
674
824
8367
78
376
840
8665
32
48
886
8993
91
5
827
9036
30
65
888
8966
71
390
825
8478
149
1085
690
7179
Left sided colitis
K51.5 [45533604]
1.6e+00
1.9e+00
—
1.0e+50
2.6e+00
2.1e+00
1.8e+00
cases:1.63%
controls:0.32%
cases:1.74%
controls:0.25%
—
—
cases:0.87%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.90%
controls:0.23%
cases:2.38%
controls:0.39%
15
29
903
9012
16
23
902
9018
—
8
0
910
9041
7
5
911
9026
17
20
879
8848
20
32
819
8232
Gastroenterology
10 [38004455]
8.3e-01
1.4e+00
2.3e+00
—
2.7e+00
1.8e+00
1.2e+00
cases:7.52%
controls:3.41%
cases:5.66%
controls:1.45%
cases:2.94%
controls:0.31%
—
—
cases:3.49%
controls:0.24%
cases:8.26%
controls:1.51%
cases:12.04%
controls:3.99%
69
308
849
8733
52
131
866
8910
27
28
891
9013
—
32
22
886
9009
74
134
822
8734
101
330
738
7934
Bacteria identified in Blood by Culture
600-7 [3023368]
7.5e-01
9.6e-01
2.8e+00
1.0e+50
3.2e+00
1.3e+00
9.6e-01
cases:3.92%
controls:1.89%
cases:2.40%
controls:0.93%
cases:2.51%
controls:0.15%
cases:4.47%
controls:0.00%
cases:3.05%
controls:0.12%
cases:3.01%
controls:0.87%
cases:8.22%
controls:3.32%
36
171
882
8870
22
84
896
8957
23
14
895
9027
41
0
877
9041
28
11
890
9020
27
77
869
8791
69
274
770
7990
Erysipelas
A46 [45561706]
1.1e+00
2.0e+00
3.8e+00
—
—
1.9e+00
1.1e+00
cases:2.83%
controls:0.98%
cases:2.72%
controls:0.39%
cases:3.92%
controls:0.09%
—
—
—
—
cases:2.12%
controls:0.33%
cases:3.81%
controls:1.29%
26
89
892
8952
25
35
893
9006
36
8
882
9033
—
—
19
29
877
8839
32
107
807
8157
Differential panel, method unspecified - Blood
69738-3 [42870588]
6.9e-01
1.3e+00
2.3e+00
—
2.7e+00
1.7e+00
1.1e+00
cases:7.08%
controls:3.68%
cases:8.06%
controls:2.36%
cases:4.90%
controls:0.52%
—
—
cases:6.75%
controls:0.49%
cases:10.83%
controls:2.12%
cases:15.26%
controls:5.48%
65
333
853
8708
74
213
844
8828
45
47
873
8994
—
62
44
856
8987
97
188
799
8680
128
453
711
7811
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
7.1e-01
1.1e+00
2.5e+00
—
2.6e+00
1.7e+00
1.1e+00
cases:4.68%
controls:2.37%
cases:4.14%
controls:1.40%
cases:2.94%
controls:0.24%
—
—
cases:3.38%
controls:0.25%
cases:6.70%
controls:1.26%
cases:10.85%
controls:4.04%
43
214
875
8827
38
127
880
8914
27
22
891
9019
—
31
23
887
9008
60
112
836
8756
91
334
748
7930
Ulcerative colitis, unspecified
K51.9 [45605941]
1.8e+00
3.2e+00
—
1.0e+50
1.0e+50
2.6e+00
1.9e+00
cases:1.53%
controls:0.24%
cases:1.63%
controls:0.07%
—
—
cases:0.87%
controls:0.00%
cases:0.87%
controls:0.00%
cases:1.34%
controls:0.10%
cases:2.03%
controls:0.30%
14
22
904
9019
15
6
903
9035
—
8
0
910
9041
8
0
910
9031
12
9
884
8859
17
25
822
8239
Crohn disease of small intestine
K50.0 [45596324]
1.9e+00
2.3e+00
—
1.0e+50
—
2.8e+00
2.5e+00
cases:0.76%
controls:0.11%
cases:0.65%
controls:0.07%
—
—
cases:0.54%
controls:0.00%
—
—
cases:1.34%
controls:0.08%
cases:1.55%
controls:0.13%
7
10
911
9031
6
6
912
9035
—
5
0
913
9041
—
12
7
884
8861
13
11
826
8253
Pulmonary Disease
29 [38004472]
9.5e-01
9.0e-01
1.8e+00
—
2.5e+00
1.9e+00
1.4e+00
cases:11.00%
controls:4.55%
cases:5.88%
controls:2.49%
cases:2.72%
controls:0.46%
—
—
cases:5.66%
controls:0.50%
cases:16.07%
controls:2.67%
cases:20.38%
controls:5.78%
101
411
817
8630
54
225
864
8816
25
42
893
8999
—
52
45
866
8986
144
237
752
8631
171
478
668
7786
Outpatient Visit
OP [9202]
2.1e-01
3.9e-01
9.3e-01
4.7e+00
1.9e+00
1.0e+00
5.2e-01
cases:62.96%
controls:57.86%
cases:47.93%
controls:38.34%
cases:19.50%
controls:8.74%
cases:29.19%
controls:0.37%
cases:38.34%
controls:8.80%
cases:64.84%
controls:39.78%
cases:77.23%
controls:66.90%
578
5231
340
3810
440
3466
478
5575
179
790
739
8251
268
33
650
9008
352
795
566
8236
581
3528
315
5340
648
5529
191
2735
Intravenous
ZX120 [2001311495]
1.4e+00
1.6e+00
—
—
2.5e+00
2.4e+00
1.5e+00
cases:2.51%
controls:0.64%
cases:1.53%
controls:0.30%
—
—
—
—
cases:0.65%
controls:0.06%
cases:2.34%
controls:0.21%
cases:2.26%
controls:0.52%
23
58
895
8983
14
27
904
9014
—
—
6
5
912
9026
21
19
875
8849
19
43
820
8221
Basophils [#/volume] in Blood
26444-0 [3006315]
5.7e-01
1.1e+00
2.3e+00
—
2.7e+00
1.6e+00
1.0e+00
cases:10.68%
controls:6.33%
cases:11.22%
controls:3.85%
cases:7.41%
controls:0.77%
—
—
cases:9.59%
controls:0.74%
cases:16.18%
controls:3.60%
cases:21.57%
controls:9.12%
98
572
820
8469
103
348
815
8693
68
70
850
8971
—
88
67
830
8964
145
319
751
8549
181
754
658
7510
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.8e-01
1.1e+00
2.3e+00
—
2.7e+00
1.6e+00
1.0e+00
cases:10.68%
controls:6.28%
cases:11.22%
controls:3.85%
cases:7.41%
controls:0.79%
—
—
cases:9.69%
controls:0.74%
cases:16.07%
controls:3.57%
cases:21.22%
controls:9.03%
98
568
820
8473
103
348
815
8693
68
71
850
8970
—
89
67
829
8964
144
317
752
8551
178
746
661
7518
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.3e-01
1.1e+00
2.4e+00
—
2.7e+00
1.6e+00
1.0e+00
cases:9.69%
controls:5.95%
cases:10.13%
controls:3.51%
cases:7.41%
controls:0.75%
—
—
cases:8.61%
controls:0.65%
cases:14.51%
controls:3.26%
cases:19.90%
controls:8.34%
89
538
829
8503
93
317
825
8724
68
68
850
8973
—
79
59
839
8972
130
289
766
8579
167
689
672
7575
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.1e-01
1.2e+00
2.4e+00
—
2.7e+00
1.6e+00
9.8e-01
cases:9.48%
controls:5.91%
cases:10.46%
controls:3.50%
cases:7.41%
controls:0.75%
—
—
cases:8.61%
controls:0.65%
cases:14.51%
controls:3.29%
cases:19.67%
controls:8.39%
87
534
831
8507
96
316
822
8725
68
68
850
8973
—
79
59
839
8972
130
292
766
8576
165
693
674
7571
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.3e-01
1.1e+00
2.4e+00
—
2.6e+00
1.6e+00
9.9e-01
cases:9.69%
controls:5.93%
cases:10.24%
controls:3.50%
cases:7.41%
controls:0.75%
—
—
cases:8.61%
controls:0.66%
cases:14.62%
controls:3.29%
cases:19.55%
controls:8.31%
89
536
829
8505
94
316
824
8725
68
68
850
8973
—
79
60
839
8971
131
292
765
8576
164
687
675
7577
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.2e-01
1.1e+00
2.3e+00
—
2.7e+00
1.6e+00
1.0e+00
cases:10.78%
controls:6.68%
cases:11.33%
controls:4.00%
cases:7.95%
controls:0.83%
—
—
cases:9.69%
controls:0.74%
cases:16.18%
controls:3.69%
cases:22.17%
controls:9.46%
99
604
819
8437
104
362
814
8679
73
75
845
8966
—
89
67
829
8964
145
327
751
8541
186
782
653
7482
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.1e-01
1.1e+00
2.4e+00
—
2.6e+00
1.6e+00
9.8e-01
cases:9.48%
controls:5.94%
cases:10.13%
controls:3.47%
cases:7.30%
controls:0.74%
—
—
cases:8.39%
controls:0.65%
cases:14.17%
controls:3.36%
cases:19.90%
controls:8.52%
87
537
831
8504
93
314
825
8727
67
67
851
8974
—
77
59
841
8972
127
298
769
8570
167
704
672
7560
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.5e-01
1.1e+00
2.3e+00
—
2.6e+00
1.6e+00
9.8e-01
cases:10.78%
controls:6.54%
cases:11.33%
controls:4.00%
cases:7.52%
controls:0.82%
—
—
cases:9.69%
controls:0.79%
cases:16.18%
controls:3.73%
cases:21.81%
controls:9.51%
99
591
819
8450
104
362
814
8679
69
74
849
8967
—
89
71
829
8960
145
331
751
8537
183
786
656
7478
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.0e-01
1.1e+00
2.3e+00
—
2.6e+00
1.6e+00
9.5e-01
cases:9.69%
controls:6.12%
cases:10.24%
controls:3.67%
cases:7.41%
controls:0.77%
—
—
cases:8.61%
controls:0.70%
cases:14.62%
controls:3.39%
cases:19.90%
controls:8.80%
89
553
829
8488
94
332
824
8709
68
70
850
8971
—
79
63
839
8968
131
301
765
8567
167
727
672
7537
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
8.0e-01
1.3e+00
2.5e+00
—
2.9e+00
9.7e-01
6.3e-01
cases:8.17%
controls:3.84%
cases:4.14%
controls:1.16%
cases:1.31%
controls:0.11%
—
—
cases:2.07%
controls:0.12%
cases:3.13%
controls:1.21%
cases:7.99%
controls:4.40%
75
347
843
8694
38
105
880
8936
12
10
906
9031
—
19
11
899
9020
28
107
868
8761
67
364
772
7900
Thorax X-ray examination
GD1AA [2001303617]
7.4e-01
1.0e+00
2.1e+00
—
2.1e+00
1.7e+00
1.2e+00
cases:8.93%
controls:4.46%
cases:4.79%
controls:1.80%
cases:1.63%
controls:0.20%
—
—
cases:2.94%
controls:0.35%
cases:8.37%
controls:1.57%
cases:15.38%
controls:5.01%
82
403
836
8638
44
163
874
8878
15
18
903
9023
—
27
32
891
8999
75
139
821
8729
129
414
710
7850
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
1.2e+00
1.4e+00
1.6e+00
—
3.2e+00
2.1e+00
1.1e+00
cases:2.83%
controls:0.91%
cases:2.18%
controls:0.55%
cases:0.65%
controls:0.13%
—
—
cases:1.85%
controls:0.08%
cases:3.79%
controls:0.47%
cases:4.77%
controls:1.62%
26
82
892
8959
20
50
898
8991
6
12
912
9029
—
17
7
901
9024
34
42
862
8826
40
134
799
8130
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
7.7e-01
1.1e+00
3.1e+00
1.0e+50
1.9e+00
1.2e+00
7.4e-01
cases:4.47%
controls:2.11%
cases:2.51%
controls:0.84%
cases:2.07%
controls:0.10%
cases:1.74%
controls:0.00%
cases:0.87%
controls:0.13%
cases:2.57%
controls:0.82%
cases:6.32%
controls:3.11%
41
191
877
8850
23
76
895
8965
19
9
899
9032
16
0
902
9041
8
12
910
9019
23
73
873
8795
53
257
786
8007
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.3e-01
1.1e+00
2.6e+00
—
2.9e+00
1.4e+00
6.8e-01
cases:14.27%
controls:10.73%
cases:15.25%
controls:5.45%
cases:10.89%
controls:0.87%
—
—
cases:10.46%
controls:0.66%
cases:18.08%
controls:5.38%
cases:25.39%
controls:14.75%
131
970
787
8071
140
493
778
8548
100
79
818
8962
—
96
60
822
8971
162
477
734
8391
213
1219
626
7045
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.4e-01
4.0e-01
1.6e+00
4.3e+00
1.6e+00
4.5e-01
3.4e-01
cases:15.36%
controls:12.44%
cases:14.49%
controls:10.18%
cases:9.59%
controls:2.16%
cases:6.64%
controls:0.10%
cases:8.82%
controls:1.96%
cases:16.29%
controls:11.05%
cases:28.25%
controls:21.89%
141
1125
777
7916
133
920
785
8121
88
195
830
8846
61
9
857
9032
81
177
837
8854
146
980
750
7888
237
1809
602
6455
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
8.9e-01
1.6e+00
3.0e+00
1.0e+50
—
1.9e+00
1.2e+00
cases:3.38%
controls:1.42%
cases:3.81%
controls:0.80%
cases:1.74%
controls:0.09%
cases:0.65%
controls:0.00%
—
—
cases:4.69%
controls:0.72%
cases:6.67%
controls:2.12%
31
128
887
8913
35
72
883
8969
16
8
902
9033
6
0
912
9041
—
42
64
854
8804
56
175
783
8089
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
1.5e+00
2.1e+00
1.0e+50
1.0e+50
—
3.1e+00
1.9e+00
cases:1.09%
controls:0.25%
cases:1.20%
controls:0.14%
cases:0.54%
controls:0.00%
cases:0.54%
controls:0.00%
—
—
cases:2.46%
controls:0.11%
cases:2.03%
controls:0.31%
10
23
908
9018
11
13
907
9028
5
0
913
9041
5
0
913
9041
—
22
10
874
8858
17
26
822
8238
Fever, unspecified
R50.9 [45582716]
1.0e+00
1.3e+00
3.6e+00
1.0e+50
—
1.7e+00
9.3e-01
cases:2.72%
controls:0.97%
cases:1.31%
controls:0.38%
cases:2.29%
controls:0.07%
cases:2.83%
controls:0.00%
—
—
cases:1.79%
controls:0.33%
cases:3.46%
controls:1.39%
25
88
893
8953
12
34
906
9007
21
6
897
9035
26
0
892
9041
—
16
29
880
8839
29
115
810
8149
cefalexin; oral
J01DB01 [21602870]
4.5e-01
1.1e+00
2.9e+00
—
2.4e+00
8.6e-01
6.8e-01
cases:34.53%
controls:25.09%
cases:19.72%
controls:7.48%
cases:12.96%
controls:0.81%
—
—
cases:8.17%
controls:0.78%
cases:16.18%
controls:7.52%
cases:39.69%
controls:25.10%
317
2268
601
6773
181
676
737
8365
119
73
799
8968
—
75
70
843
8961
145
667
751
8201
333
2074
506
6190
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
1.4e-01
1.3e+00
3.6e+00
1.0e+50
2.5e+00
9.7e-01
4.4e-01
cases:3.16%
controls:2.77%
cases:3.81%
controls:1.02%
cases:3.27%
controls:0.09%
cases:4.25%
controls:0.00%
cases:1.96%
controls:0.17%
cases:2.57%
controls:0.99%
cases:6.67%
controls:4.39%
29
250
889
8791
35
92
883
8949
30
8
888
9033
39
0
879
9041
18
15
900
9016
23
88
873
8780
56
363
783
7901
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
6.9e-02
4.1e-01
1.6e+00
4.3e+00
1.6e+00
5.1e-01
2.1e-01
cases:20.26%
controls:19.17%
cases:21.68%
controls:15.54%
cases:14.81%
controls:3.43%
cases:11.44%
controls:0.18%
cases:14.05%
controls:3.29%
cases:24.44%
controls:16.33%
cases:34.80%
controls:30.15%
186
1733
732
7308
199
1405
719
7636
136
310
782
8731
105
16
813
9025
129
297
789
8734
219
1448
677
7420
292
2492
547
5772
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
8.9e-02
4.5e-01
1.6e+00
4.0e+00
1.7e+00
5.9e-01
2.4e-01
cases:19.61%
controls:18.24%
cases:20.26%
controls:13.99%
cases:12.09%
controls:2.75%
cases:6.43%
controls:0.12%
cases:12.31%
controls:2.56%
cases:23.10%
controls:14.26%
cases:34.33%
controls:29.13%
180
1649
738
7392
186
1265
732
7776
111
249
807
8792
59
11
859
9030
113
231
805
8800
207
1265
689
7603
288
2407
551
5857
pH of Serum or Plasma
2753-2 [3018418]
6.0e-01
1.1e+00
1.9e+00
—
2.6e+00
1.4e+00
7.9e-01
cases:5.01%
controls:2.82%
cases:4.14%
controls:1.45%
cases:1.74%
controls:0.27%
—
—
cases:2.83%
controls:0.22%
cases:6.03%
controls:1.58%
cases:10.01%
controls:4.79%
46
255
872
8786
38
131
880
8910
16
24
902
9017
—
26
20
892
9011
54
140
842
8728
84
396
755
7868
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.8e-02
3.2e-01
1.6e+00
4.5e+00
1.7e+00
5.5e-01
1.5e-01
cases:14.16%
controls:13.70%
cases:14.92%
controls:11.26%
cases:11.22%
controls:2.52%
cases:10.24%
controls:0.13%
cases:12.75%
controls:2.54%
cases:18.86%
controls:11.86%
cases:25.51%
controls:22.77%
130
1239
788
7802
137
1018
781
8023
103
228
815
8813
94
12
824
9029
117
229
801
8802
169
1052
727
7816
214
1882
625
6382
Platelets [#/volume] in Blood
26515-7 [3007461]
-3.1e-03
3.5e-01
1.6e+00
4.2e+00
1.6e+00
4.7e-01
1.5e-01
cases:22.22%
controls:22.28%
cases:24.40%
controls:18.58%
cases:18.41%
controls:4.27%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.03%
cases:27.34%
controls:19.09%
cases:37.31%
controls:33.94%
204
2014
714
7027
224
1680
694
7361
169
386
749
8655
127
21
791
9020
163
364
755
8667
245
1693
651
7175
313
2805
526
5459
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-4.5e-03
3.5e-01
1.6e+00
4.2e+00
1.6e+00
4.6e-01
1.4e-01
cases:22.33%
controls:22.41%
cases:24.62%
controls:18.76%
cases:18.52%
controls:4.31%
cases:13.94%
controls:0.23%
cases:17.76%
controls:4.10%
cases:27.34%
controls:19.17%
cases:37.19%
controls:34.03%
205
2026
713
7015
226
1696
692
7345
170
390
748
8651
128
21
790
9020
163
370
755
8661
245
1700
651
7168
312
2812
527
5452
MCH [Entitic mass]
28539-5 [3035941]
2.5e-03
3.4e-01
1.6e+00
4.2e+00
1.6e+00
4.7e-01
1.4e-01
cases:22.33%
controls:22.29%
cases:24.40%
controls:18.68%
cases:18.41%
controls:4.28%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.06%
cases:27.34%
controls:19.11%
cases:37.19%
controls:33.98%
205
2015
713
7026
224
1689
694
7352
169
387
749
8654
127
21
791
9020
163
367
755
8664
245
1695
651
7173
312
2808
527
5456
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.3e-03
3.4e-01
1.6e+00
4.2e+00
1.6e+00
4.6e-01
1.4e-01
cases:22.33%
controls:22.31%
cases:24.40%
controls:18.74%
cases:18.41%
controls:4.29%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.05%
cases:27.34%
controls:19.14%
cases:37.31%
controls:34.02%
205
2017
713
7024
224
1694
694
7347
169
388
749
8653
127
21
791
9020
163
366
755
8665
245
1697
651
7171
313
2811
526
5453
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
9.6e-02
3.7e-01
1.5e+00
4.5e+00
1.5e+00
4.1e-01
1.9e-01
cases:18.74%
controls:17.32%
cases:18.52%
controls:13.53%
cases:11.22%
controls:2.77%
cases:11.00%
controls:0.13%
cases:10.46%
controls:2.60%
cases:19.75%
controls:14.10%
cases:30.99%
controls:27.07%
172
1566
746
7475
170
1223
748
7818
103
250
815
8791
101
12
817
9029
96
235
822
8796
177
1250
719
7618
260
2237
579
6027
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
6.1e-04
3.4e-01
1.6e+00
4.2e+00
1.6e+00
4.6e-01
1.4e-01
cases:22.33%
controls:22.32%
cases:24.40%
controls:18.73%
cases:18.41%
controls:4.29%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.06%
cases:27.34%
controls:19.15%
cases:37.19%
controls:34.02%
205
2018
713
7023
224
1693
694
7348
169
388
749
8653
127
21
791
9020
163
367
755
8664
245
1698
651
7170
312
2811
527
5453
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.6e-03
3.4e-01
1.6e+00
4.2e+00
1.6e+00
4.6e-01
1.4e-01
cases:22.33%
controls:22.38%
cases:24.40%
controls:18.75%
cases:18.41%
controls:4.30%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.09%
cases:27.34%
controls:19.16%
cases:37.19%
controls:34.09%
205
2023
713
7018
224
1695
694
7346
169
389
749
8652
127
21
791
9020
163
369
755
8662
245
1699
651
7169
312
2817
527
5447
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-2.6e-05
3.4e-01
1.6e+00
4.2e+00
1.6e+00
4.6e-01
1.4e-01
cases:22.33%
controls:22.33%
cases:24.40%
controls:18.74%
cases:18.30%
controls:4.30%
cases:13.83%
controls:0.23%
cases:17.76%
controls:4.07%
cases:27.34%
controls:19.12%
cases:37.31%
controls:34.00%
205
2019
713
7022
224
1694
694
7347
168
389
750
8652
127
21
791
9020
163
368
755
8663
245
1696
651
7172
313
2810
526
5454
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.0e-01
3.7e-01
1.5e+00
4.5e+00
1.5e+00
4.3e-01
1.9e-01
cases:18.63%
controls:17.13%
cases:18.19%
controls:13.36%
cases:10.89%
controls:2.74%
cases:11.00%
controls:0.13%
cases:10.24%
controls:2.55%
cases:19.87%
controls:13.93%
cases:30.87%
controls:26.91%
171
1549
747
7492
167
1208
751
7833
100
248
818
8793
101
12
817
9029
94
230
824
8801
178
1235
718
7633
259
2224
580
6040
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.0e-01
1.2e+00
1.7e+00
—
2.4e+00
1.4e+00
9.5e-01
cases:8.06%
controls:4.60%
cases:7.41%
controls:2.43%
cases:2.83%
controls:0.55%
—
—
cases:4.14%
controls:0.40%
cases:8.48%
controls:2.23%
cases:16.09%
controls:6.92%
74
416
844
8625
68
220
850
8821
26
50
892
8991
—
38
36
880
8995
76
198
820
8670
135
572
704
7692
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
6.0e-01
9.9e-01
1.9e+00
—
2.8e+00
1.1e+00
7.9e-01
cases:5.99%
controls:3.38%
cases:5.12%
controls:1.97%
cases:1.74%
controls:0.27%
—
—
cases:2.72%
controls:0.18%
cases:5.13%
controls:1.76%
cases:11.56%
controls:5.60%
55
306
863
8735
47
178
871
8863
16
24
902
9017
—
25
16
893
9015
46
156
850
8712
97
463
742
7801
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
6.1e-01
9.6e-01
2.0e+00
—
2.4e+00
1.3e+00
8.0e-01
cases:7.73%
controls:4.37%
cases:6.21%
controls:2.48%
cases:3.27%
controls:0.44%
—
—
cases:4.14%
controls:0.40%
cases:8.37%
controls:2.41%
cases:14.78%
controls:7.22%
71
395
847
8646
57
224
861
8817
30
40
888
9001
—
38
36
880
8995
75
214
821
8654
124
597
715
7667
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.4e-01
1.0e+00
2.0e+00
—
2.5e+00
1.3e+00
7.1e-01
cases:8.06%
controls:4.84%
cases:7.19%
controls:2.69%
cases:3.70%
controls:0.51%
—
—
cases:4.79%
controls:0.42%
cases:9.38%
controls:2.80%
cases:15.61%
controls:8.31%
74
438
844
8603
66
243
852
8798
34
46
884
8995
—
44
38
874
8993
84
248
812
8620
131
687
708
7577
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
5.3e-01
1.7e+00
2.7e+00
—
2.5e+00
1.1e+00
5.6e-01
cases:3.05%
controls:1.83%
cases:3.16%
controls:0.60%
cases:0.98%
controls:0.07%
—
—
cases:0.98%
controls:0.08%
cases:1.56%
controls:0.54%
cases:4.29%
controls:2.49%
28
165
890
8876
29
54
889
8987
9
6
909
9035
—
9
7
909
9024
14
48
882
8820
36
206
803
8058
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-5.8e-02
3.1e-01
1.5e+00
4.5e+00
1.5e+00
4.0e-01
5.6e-02
cases:15.90%
controls:16.70%
cases:16.56%
controls:12.66%
cases:11.76%
controls:2.82%
cases:10.68%
controls:0.13%
cases:11.66%
controls:2.76%
cases:18.42%
controls:13.10%
cases:26.82%
controls:25.74%
146
1510
772
7531
152
1145
766
7896
108
255
810
8786
98
12
820
9029
107
249
811
8782
165
1162
731
7706
225
2127
614
6137
Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]
1.4e+00
2.4e+00
1.0e+50
—
1.0e+50
3.2e+00
2.3e+00
cases:0.65%
controls:0.15%
cases:0.87%
controls:0.08%
cases:0.76%
controls:0.00%
—
—
cases:1.42%
controls:0.00%
cases:2.12%
controls:0.09%
cases:2.03%
controls:0.21%
6
14
912
9027
8
7
910
9034
7
0
911
9041
—
13
0
905
9031
19
8
877
8860
17
17
822
8247
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
6.0e-01
8.6e-01
1.7e+00
1.0e+50
3.1e+00
9.4e-01
6.3e-01
cases:4.25%
controls:2.38%
cases:3.27%
controls:1.40%
cases:0.98%
controls:0.19%
cases:2.40%
controls:0.00%
cases:1.96%
controls:0.09%
cases:3.13%
controls:1.24%
cases:7.87%
controls:4.37%
39
215
879
8826
30
127
888
8914
9
17
909
9024
22
0
896
9041
18
8
900
9023
28
110
868
8758
66
361
773
7903
betamethasone
A07EA04 [21600656]
6.4e-01
1.0e+00
2.0e+00
—
2.6e+00
9.8e-01
5.6e-01
cases:8.61%
controls:4.71%
cases:4.79%
controls:1.78%
cases:1.74%
controls:0.24%
—
—
cases:2.94%
controls:0.22%
cases:4.91%
controls:1.89%
cases:10.01%
controls:5.99%
79
426
839
8615
44
161
874
8880
16
22
902
9019
—
27
20
891
9011
44
168
852
8700
84
495
755
7769
betamethasone
D07AC01 [21602120]
6.4e-01
1.0e+00
2.0e+00
—
2.6e+00
9.8e-01
5.6e-01
cases:8.61%
controls:4.71%
cases:4.79%
controls:1.78%
cases:1.74%
controls:0.24%
—
—
cases:2.94%
controls:0.22%
cases:4.91%
controls:1.89%
cases:10.01%
controls:5.99%
79
426
839
8615
44
161
874
8880
16
22
902
9019
—
27
20
891
9011
44
168
852
8700
84
495
755
7769
betamethasone
S02BA07 [21605169]
6.4e-01
1.0e+00
2.0e+00
—
2.6e+00
9.8e-01
5.6e-01
cases:8.61%
controls:4.71%
cases:4.79%
controls:1.78%
cases:1.74%
controls:0.24%
—
—
cases:2.94%
controls:0.22%
cases:4.91%
controls:1.89%
cases:10.01%
controls:5.99%
79
426
839
8615
44
161
874
8880
16
22
902
9019
—
27
20
891
9011
44
168
852
8700
84
495
755
7769
betamethasone
C05AA05 [21601610]
6.4e-01
1.0e+00
2.0e+00
—
2.6e+00
9.8e-01
5.6e-01
cases:8.61%
controls:4.71%
cases:4.79%
controls:1.78%
cases:1.74%
controls:0.24%
—
—
cases:2.94%
controls:0.22%
cases:4.91%
controls:1.89%
cases:10.01%
controls:5.99%
79
426
839
8615
44
161
874
8880
16
22
902
9019
—
27
20
891
9011
44
168
852
8700
84
495
755
7769
Bacteria [Presence] in Urine
87829-8 [36304419]
6.2e-01
8.6e-01
1.8e+00
1.0e+50
2.8e+00
9.6e-01
6.7e-01
cases:4.14%
controls:2.28%
cases:3.16%
controls:1.36%
cases:1.09%
controls:0.18%
cases:2.40%
controls:0.00%
cases:1.85%
controls:0.11%
cases:3.01%
controls:1.17%
cases:7.75%
controls:4.14%
38
206
880
8835
29
123
889
8918
10
16
908
9025
22
0
896
9041
17
10
901
9021
27
104
869
8764
65
342
774
7922
CBC panel - Blood by Automated count
58410-2 [40761511]
1.1e-02
2.8e-01
1.5e+00
4.1e+00
1.5e+00
4.8e-01
1.6e-01
cases:18.74%
controls:18.57%
cases:16.23%
controls:12.82%
cases:10.68%
controls:2.48%
cases:7.73%
controls:0.13%
cases:9.91%
controls:2.29%
cases:19.31%
controls:12.91%
cases:30.87%
controls:27.59%
172
1679
746
7362
149
1159
769
7882
98
224
820
8817
71
12
847
9029
91
207
827
8824
173
1145
723
7723
259
2280
580
5984
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
1.4e+00
1.2e+00
—
1.0e+50
2.8e+00
1.5e+00
8.6e-01
cases:1.85%
controls:0.49%
cases:1.42%
controls:0.43%
—
—
cases:0.65%
controls:0.00%
cases:0.87%
controls:0.06%
cases:1.45%
controls:0.32%
cases:3.58%
controls:1.55%
17
44
901
8997
13
39
905
9002
—
6
0
912
9041
8
5
910
9026
13
28
883
8840
30
128
809
8136
pH of Venous blood
2746-6 [3012544]
1.3e+00
1.3e+00
—
1.0e+50
2.8e+00
1.5e+00
7.9e-01
cases:1.85%
controls:0.50%
cases:1.42%
controls:0.41%
—
—
cases:0.65%
controls:0.00%
cases:0.87%
controls:0.06%
cases:1.45%
controls:0.32%
cases:3.34%
controls:1.55%
17
45
901
8996
13
37
905
9004
—
6
0
912
9041
8
5
910
9026
13
28
883
8840
28
128
811
8136
Base excess in Venous blood by calculation
1927-3 [3002032]
1.4e+00
1.2e+00
—
1.0e+50
2.8e+00
1.5e+00
7.9e-01
cases:1.85%
controls:0.49%
cases:1.42%
controls:0.42%
—
—
cases:0.65%
controls:0.00%
cases:0.87%
controls:0.06%
cases:1.45%
controls:0.32%
cases:3.34%
controls:1.55%
17
44
901
8997
13
38
905
9003
—
6
0
912
9041
8
5
910
9026
13
28
883
8840
28
128
811
8136
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
6.3e-01
9.1e-01
1.8e+00
—
2.6e+00
9.8e-01
6.8e-01
cases:5.12%
controls:2.80%
cases:4.14%
controls:1.70%
cases:1.42%
controls:0.24%
—
—
cases:2.07%
controls:0.16%
cases:3.79%
controls:1.47%
cases:9.54%
controls:5.07%
47
253
871
8788
38
154
880
8887
13
22
905
9019
—
19
14
899
9017
34
130
862
8738
80
419
759
7845
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
9.1e-01
3.3e+00
—
1.0e+50
1.0e+50
2.8e+00
1.5e+00
cases:1.09%
controls:0.44%
cases:2.29%
controls:0.09%
—
—
cases:5.23%
controls:0.00%
cases:1.74%
controls:0.00%
cases:3.35%
controls:0.21%
cases:2.38%
controls:0.53%
10
40
908
9001
21
8
897
9033
—
48
0
870
9041
16
0
902
9031
30
19
866
8849
20
44
819
8220
Predominantly allergic asthma
J45.0 [45557624]
1.4e+00
1.1e+00
1.5e+00
—
2.2e+00
1.6e+00
1.3e+00
cases:3.59%
controls:0.95%
cases:1.42%
controls:0.49%
cases:0.65%
controls:0.14%
—
—
cases:0.98%
controls:0.11%
cases:2.46%
controls:0.51%
cases:3.93%
controls:1.06%
33
86
885
8955
13
44
905
8997
6
13
912
9028
—
9
10
909
9021
22
45
874
8823
33
88
806
8176
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.5e+00
2.9e+00
—
—
1.0e+50
2.8e+00
1.8e+00
cases:0.87%
controls:0.20%
cases:0.98%
controls:0.06%
—
—
—
—
cases:1.53%
controls:0.00%
cases:0.89%
controls:0.06%
cases:1.67%
controls:0.27%
8
18
910
9023
9
5
909
9036
—
—
14
0
904
9031
8
5
888
8863
14
22
825
8242
Asthma, unspecified
J45.9 [45562456]
8.5e-01
1.0e+00
2.1e+00
1.0e+50
1.7e+00
1.1e+00
7.2e-01
cases:4.68%
controls:2.06%
cases:2.61%
controls:0.97%
cases:0.98%
controls:0.12%
cases:0.98%
controls:0.00%
cases:0.87%
controls:0.16%
cases:3.01%
controls:1.04%
cases:5.60%
controls:2.80%
43
186
875
8855
24
88
894
8953
9
11
909
9030
9
0
909
9041
8
14
910
9017
27
92
869
8776
47
231
792
8033
Crohn disease, unspecified
K50.9 [45562490]
2.7e+00
2.3e+00
—
—
—
—
2.4e+00
cases:0.98%
controls:0.07%
cases:0.65%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.12%
9
6
909
9035
6
6
912
9035
—
—
—
—
11
10
828
8254
hydrocortisone; oral, parenteral
H02AB09 [21602737]
7.8e-01
1.3e+00
2.6e+00
—
2.0e+00
1.4e+00
7.6e-01
cases:2.40%
controls:1.12%
cases:1.63%
controls:0.43%
cases:0.87%
controls:0.07%
—
—
cases:0.76%
controls:0.10%
cases:1.56%
controls:0.41%
cases:2.50%
controls:1.19%
22
101
896
8940
15
39
903
9002
8
6
910
9035
—
7
9
911
9022
14
36
882
8832
21
98
818
8166
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
1.3e+00
2.0e+00
—
—
1.0e+50
2.4e+00
1.5e+00
cases:1.74%
controls:0.46%
cases:0.87%
controls:0.12%
—
—
—
—
cases:0.76%
controls:0.00%
cases:0.89%
controls:0.08%
cases:3.10%
controls:0.68%
16
42
902
8999
8
11
910
9030
—
—
7
0
911
9031
8
7
888
8861
26
56
813
8208
Sarcoidosis of lung
D86.0 [45576422]
—
—
1.0e+50
1.0e+50
—
4.1e+00
3.2e+00
—
—
—
—
cases:0.54%
controls:0.00%
cases:1.09%
controls:0.00%
—
—
cases:3.24%
controls:0.06%
cases:2.86%
controls:0.12%
—
—
5
0
913
9041
10
0
908
9041
—
29
5
867
8863
24
10
815
8254
Ulcerative colitis and Crohn's disease
208 [2001600206]
1.6e+00
2.6e+00
—
—
—
3.0e+00
1.1e+00
cases:1.42%
controls:0.29%
cases:0.76%
controls:0.06%
—
—
—
—
—
—
cases:1.56%
controls:0.08%
cases:0.60%
controls:0.21%
13
26
905
9015
7
5
911
9036
—
—
—
14
7
882
8861
5
17
834
8247
Leukocytes [#/volume] in Urine
30405-5 [3018095]
6.0e-01
9.0e-01
1.9e+00
—
2.3e+00
7.9e-01
6.6e-01
cases:5.56%
controls:3.12%
cases:4.79%
controls:2.01%
cases:1.85%
controls:0.28%
—
—
cases:2.40%
controls:0.24%
cases:4.02%
controls:1.86%
cases:11.56%
controls:6.30%
51
282
867
8759
44
182
874
8859
17
25
901
9016
—
22
22
896
9009
36
165
860
8703
97
521
742
7743
clindamycin; oral, parenteral
J01FF01 [21602985]
6.1e-01
1.3e+00
2.8e+00
—
—
1.4e+00
8.5e-01
cases:4.58%
controls:2.53%
cases:2.61%
controls:0.71%
cases:1.42%
controls:0.09%
—
—
—
—
cases:2.68%
controls:0.64%
cases:6.67%
controls:2.96%
42
229
876
8812
24
64
894
8977
13
8
905
9033
—
—
24
57
872
8811
56
245
783
8019
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
6.5e-01
7.4e-01
2.0e+00
1.0e+50
3.1e+00
9.8e-01
8.6e-01
cases:3.59%
controls:1.91%
cases:2.18%
controls:1.05%
cases:0.87%
controls:0.12%
cases:1.63%
controls:0.00%
cases:1.63%
controls:0.08%
cases:2.46%
controls:0.94%
cases:6.32%
controls:2.77%
33
173
885
8868
20
95
898
8946
8
11
910
9030
15
0
903
9041
15
7
903
9024
22
83
874
8785
53
229
786
8035
Laceration/cut
S18 [2002000983]
4.5e-01
9.5e-01
1.7e+00
—
2.7e+00
1.0e+00
5.2e-01
cases:6.10%
controls:3.98%
cases:3.49%
controls:1.37%
cases:0.98%
controls:0.19%
—
—
cases:2.51%
controls:0.17%
cases:3.79%
controls:1.43%
cases:9.18%
controls:5.69%
56
360
862
8681
32
124
886
8917
9
17
909
9024
—
23
15
895
9016
34
127
862
8741
77
470
762
7794
Office Visit
OMOP4822458 [581477]
2.2e-01
6.1e-01
2.0e+00
1.0e+50
2.8e+00
8.1e-01
4.8e-01
cases:9.15%
controls:7.51%
cases:4.36%
controls:2.42%
cases:2.29%
controls:0.31%
cases:2.51%
controls:0.00%
cases:5.45%
controls:0.33%
cases:5.25%
controls:2.40%
cases:10.37%
controls:6.70%
84
679
834
8362
40
219
878
8822
21
28
897
9013
23
0
895
9041
50
30
868
9001
47
213
849
8655
87
554
752
7710
Laboratory Visit
OMOP4822461 [32036]
4.8e-03
2.1e-01
1.3e+00
3.9e+00
1.3e+00
2.7e-01
2.3e-02
cases:25.71%
controls:25.62%
cases:28.32%
controls:24.34%
cases:23.53%
controls:7.68%
cases:18.63%
controls:0.46%
cases:23.09%
controls:7.75%
cases:31.58%
controls:26.11%
cases:38.62%
controls:38.08%
236
2316
682
6725
260
2201
658
6840
216
694
702
8347
171
42
747
8999
212
700
706
8331
283
2315
613
6553
324
3147
515
5117
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
1.2e+00
2.5e+00
—
—
1.0e+50
2.5e+00
1.8e+00
cases:1.20%
controls:0.35%
cases:1.09%
controls:0.09%
—
—
—
—
cases:2.51%
controls:0.00%
cases:1.56%
controls:0.14%
cases:2.26%
controls:0.40%
11
32
907
9009
10
8
908
9033
—
—
23
0
895
9031
14
12
882
8856
19
33
820
8231
Ileoscopy through colon
UJF30 [2001305028]
1.1e+00
2.3e+00
—
—
—
2.1e+00
1.1e+00
cases:1.85%
controls:0.61%
cases:1.31%
controls:0.13%
—
—
—
—
—
—
cases:1.34%
controls:0.16%
cases:2.26%
controls:0.75%
17
55
901
8986
12
12
906
9029
—
—
—
12
14
884
8854
19
62
820
8202
Other ulcerative colitis
K51.8 [45586720]
2.0e+00
—
—
—
—
2.3e+00
2.4e+00
cases:0.87%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
cases:1.07%
controls:0.10%
8
11
910
9030
—
—
—
—
6
6
890
8862
9
8
830
8256
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
4.3e-01
8.0e-01
1.6e+00
—
2.1e+00
9.8e-01
7.1e-01
cases:8.28%
controls:5.54%
cases:6.86%
controls:3.20%
cases:3.16%
controls:0.64%
—
—
cases:4.90%
controls:0.60%
cases:7.59%
controls:3.00%
cases:15.61%
controls:8.36%
76
501
842
8540
63
289
855
8752
29
58
889
8983
—
45
54
873
8977
68
266
828
8602
131
691
708
7573
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.1e+00
1.1e+00
—
—
1.9e+00
1.4e+00
1.2e+00
cases:4.25%
controls:1.52%
cases:1.74%
controls:0.56%
—
—
—
—
cases:0.87%
controls:0.13%
cases:2.23%
controls:0.58%
cases:4.29%
controls:1.37%
39
137
879
8904
16
51
902
8990
—
—
8
12
910
9019
20
51
876
8817
36
113
803
8151
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.9e-01
8.9e-01
1.8e+00
—
2.5e+00
8.7e-01
5.6e-01
cases:5.23%
controls:3.59%
cases:4.79%
controls:2.02%
cases:1.74%
controls:0.29%
—
—
cases:3.27%
controls:0.29%
cases:4.80%
controls:2.07%
cases:9.18%
controls:5.45%
48
325
870
8716
44
183
874
8858
16
26
902
9015
—
30
26
888
9005
43
184
853
8684
77
450
762
7814
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
7.1e-01
9.8e-01
1.7e+00
—
2.8e+00
1.3e+00
8.1e-01
cases:4.58%
controls:2.30%
cases:2.94%
controls:1.13%
cases:0.76%
controls:0.14%
—
—
cases:1.09%
controls:0.07%
cases:3.46%
controls:1.00%
cases:8.70%
controls:4.08%
42
208
876
8833
27
102
891
8939
7
13
911
9028
—
10
6
908
9025
31
89
865
8779
73
337
766
7927
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
1.4e-01
1.3e+00
2.6e+00
—
—
1.8e+00
8.6e-01
cases:1.42%
controls:1.23%
cases:1.53%
controls:0.42%
cases:0.76%
controls:0.06%
—
—
—
—
cases:1.67%
controls:0.29%
cases:3.81%
controls:1.65%
13
111
905
8930
14
38
904
9003
7
5
911
9036
—
—
15
26
881
8842
32
136
807
8128
pH of Specimen
17433-4 [3019225]
5.5e-01
1.2e+00
2.6e+00
—
2.0e+00
1.6e+00
1.2e+00
cases:1.63%
controls:0.95%
cases:1.53%
controls:0.49%
cases:1.42%
controls:0.11%
—
—
cases:0.54%
controls:0.08%
cases:2.23%
controls:0.47%
cases:4.05%
controls:1.21%
15
86
903
8955
14
44
904
8997
13
10
905
9031
—
5
7
913
9024
20
42
876
8826
34
100
805
8164
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.0e+00
2.0e+00
—
1.0e+50
1.0e+50
2.6e+00
1.9e+00
cases:1.09%
controls:0.39%
cases:0.98%
controls:0.13%
—
—
cases:0.54%
controls:0.00%
cases:2.40%
controls:0.00%
cases:1.67%
controls:0.12%
cases:2.74%
controls:0.42%
10
35
908
9006
9
12
909
9029
—
5
0
913
9041
22
0
896
9031
15
11
881
8857
23
35
816
8229
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
6.6e-01
9.5e-01
—
—
2.8e+00
2.5e+00
1.2e+00
cases:0.98%
controls:0.51%
cases:0.65%
controls:0.25%
—
—
—
—
cases:0.87%
controls:0.06%
cases:1.45%
controls:0.12%
cases:1.79%
controls:0.53%
9
46
909
8995
6
23
912
9018
—
—
8
5
910
9026
13
11
883
8857
15
44
824
8220
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.4e-01
8.2e-01
2.1e+00
—
2.4e+00
7.0e-01
4.4e-01
cases:7.63%
controls:5.54%
cases:7.08%
controls:3.25%
cases:3.49%
controls:0.45%
—
—
cases:4.90%
controls:0.48%
cases:6.81%
controls:3.48%
cases:15.14%
controls:10.27%
70
501
848
8540
65
294
853
8747
32
41
886
9000
—
45
43
873
8988
61
309
835
8559
127
849
712
7415
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
5.0e-01
7.5e-01
1.6e+00
—
1.9e+00
9.2e-01
6.9e-01
cases:6.75%
controls:4.20%
cases:5.23%
controls:2.54%
cases:1.42%
controls:0.29%
—
—
cases:1.42%
controls:0.21%
cases:6.92%
controls:2.88%
cases:15.38%
controls:8.35%
62
380
856
8661
48
230
870
8811
13
26
905
9015
—
13
19
905
9012
62
255
834
8613
129
690
710
7574
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.3e+00
1.9e+00
—
—
—
1.7e+00
1.4e+00
cases:2.29%
controls:0.63%
cases:1.20%
controls:0.19%
—
—
—
—
—
—
cases:1.34%
controls:0.24%
cases:3.34%
controls:0.82%
21
57
897
8984
11
17
907
9024
—
—
—
12
21
884
8847
28
68
811
8196
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
1.5e+00
1.8e+00
—
—
—
1.9e+00
1.1e+00
cases:1.96%
controls:0.44%
cases:0.87%
controls:0.14%
—
—
—
—
—
—
cases:1.23%
controls:0.18%
cases:2.38%
controls:0.81%
18
40
900
9001
8
13
910
9028
—
—
—
11
16
885
8852
20
67
819
8197
Bacterial infection, unspecified
A49.9 [45590816]
1.1e+00
1.4e+00
2.4e+00
—
—
1.8e+00
9.6e-01
cases:1.85%
controls:0.60%
cases:0.98%
controls:0.23%
cases:0.76%
controls:0.07%
—
—
—
—
cases:1.12%
controls:0.19%
cases:2.03%
controls:0.79%
17
54
901
8987
9
21
909
9020
7
6
911
9035
—
—
10
17
886
8851
17
65
822
8199
Polycythaemia vera
D45 [45595761]
2.0e+00
2.1e+00
—
—
—
2.0e+00
2.2e+00
cases:0.54%
controls:0.08%
cases:0.65%
controls:0.08%
—
—
—
—
—
—
cases:0.67%
controls:0.09%
cases:0.83%
controls:0.10%
5
7
913
9034
6
7
912
9034
—
—
—
6
8
890
8860
7
8
832
8256
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
1.5e+00
1.5e+00
—
—
—
2.2e+00
1.2e+00
cases:1.42%
controls:0.32%
cases:1.09%
controls:0.25%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:2.26%
controls:0.73%
13
29
905
9012
10
23
908
9018
—
—
—
8
9
888
8859
19
60
820
8204
Ulcerative (chronic) rectosigmoiditis
K51.3 [45533603]
1.8e+00
1.8e+00
—
—
—
2.4e+00
2.0e+00
cases:1.09%
controls:0.18%
cases:0.65%
controls:0.11%
—
—
—
—
—
—
cases:0.89%
controls:0.08%
cases:1.07%
controls:0.15%
10
16
908
9025
6
10
912
9031
—
—
—
8
7
888
8861
9
12
830
8252
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.5e-01
7.6e-01
2.1e+00
—
2.3e+00
6.6e-01
4.4e-01
cases:8.06%
controls:5.82%
cases:6.97%
controls:3.40%
cases:3.59%
controls:0.46%
—
—
cases:4.90%
controls:0.50%
cases:6.70%
controls:3.59%
cases:15.38%
controls:10.50%
74
526
844
8515
64
307
854
8734
33
42
885
8999
—
45
45
873
8986
60
318
836
8550
129
868
710
7396
oxycodone; oral, parenteral
N02AA05 [21604260]
9.7e-01
1.2e+00
—
—
1.7e+00
1.6e+00
8.8e-01
cases:1.85%
controls:0.71%
cases:1.53%
controls:0.46%
—
—
—
—
cases:1.09%
controls:0.21%
cases:2.57%
controls:0.55%
cases:3.34%
controls:1.42%
17
64
901
8977
14
42
904
8999
—
—
10
19
908
9012
23
49
873
8819
28
117
811
8147
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
—
2.2e+00
1.0e+50
1.0e+50
1.0e+50
2.3e+00
1.8e+00
—
—
cases:0.87%
controls:0.10%
cases:0.87%
controls:0.00%
cases:0.65%
controls:0.00%
cases:1.20%
controls:0.00%
cases:0.67%
controls:0.07%
cases:1.31%
controls:0.23%
—
8
9
910
9032
8
0
910
9041
6
0
912
9041
11
0
907
9031
6
6
890
8862
11
19
828
8245
hydrocortisone
S02BA01 [21605166]
5.5e-01
8.9e-01
2.5e+00
—
1.8e+00
5.7e-01
4.5e-01
cases:9.37%
controls:5.64%
cases:4.14%
controls:1.75%
cases:2.07%
controls:0.17%
—
—
cases:1.31%
controls:0.22%
cases:3.13%
controls:1.79%
cases:8.46%
controls:5.58%
86
510
832
8531
38
158
880
8883
19
15
899
9026
—
12
20
906
9011
28
159
868
8709
71
461
768
7803
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.2e-01
7.9e-01
1.9e+00
—
2.2e+00
7.7e-01
5.3e-01
cases:12.53%
controls:9.46%
cases:10.78%
controls:5.21%
cases:5.66%
controls:0.86%
—
—
cases:6.21%
controls:0.74%
cases:10.60%
controls:5.19%
cases:21.33%
controls:13.71%
115
855
803
8186
99
471
819
8570
52
78
866
8963
—
57
67
861
8964
95
460
801
8408
179
1133
660
7131
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
7.3e-01
1.3e+00
2.3e+00
—
1.3e+00
1.1e+00
7.2e-01
cases:5.88%
controls:2.93%
cases:3.70%
controls:1.02%
cases:1.74%
controls:0.18%
—
—
cases:0.87%
controls:0.23%
cases:3.79%
controls:1.25%
cases:7.51%
controls:3.81%
54
265
864
8776
34
92
884
8949
16
16
902
9025
—
8
21
910
9010
34
111
862
8757
63
315
776
7949
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.4e-01
7.5e-01
2.0e+00
—
2.3e+00
6.6e-01
4.4e-01
cases:7.84%
controls:5.73%
cases:6.97%
controls:3.41%
cases:3.38%
controls:0.46%
—
—
cases:4.79%
controls:0.50%
cases:6.70%
controls:3.56%
cases:15.26%
controls:10.41%
72
518
846
8523
64
308
854
8733
31
42
887
8999
—
44
45
874
8986
60
316
836
8552
128
860
711
7404
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.2e-01
6.8e-01
2.0e+00
—
2.3e+00
7.2e-01
4.8e-01
cases:6.21%
controls:5.02%
cases:5.23%
controls:2.71%
cases:2.51%
controls:0.35%
—
—
cases:3.49%
controls:0.35%
cases:5.58%
controls:2.81%
cases:12.28%
controls:8.00%
57
454
861
8587
48
245
870
8796
23
32
895
9009
—
32
32
886
8999
50
249
846
8619
103
661
736
7603
High resolution CT examination of lungs
GD1DD [2001303632]
1.5e+00
1.7e+00
—
—
—
2.7e+00
2.0e+00
cases:0.98%
controls:0.22%
cases:0.65%
controls:0.12%
—
—
—
—
—
—
cases:1.45%
controls:0.10%
cases:2.03%
controls:0.28%
9
20
909
9021
6
11
912
9030
—
—
—
13
9
883
8859
17
23
822
8241
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
8.4e-01
1.9e+00
—
1.0e+50
—
2.2e+00
1.2e+00
cases:3.38%
controls:1.49%
cases:2.61%
controls:0.42%
—
—
cases:0.54%
controls:0.00%
—
—
cases:3.35%
controls:0.38%
cases:6.32%
controls:1.95%
31
135
887
8906
24
38
894
9003
—
5
0
913
9041
—
30
34
866
8834
53
161
786
8103
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
1.1e+00
1.5e+00
—
—
—
2.4e+00
1.0e+00
cases:1.74%
controls:0.58%
cases:1.09%
controls:0.24%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:2.98%
controls:1.06%
16
52
902
8989
10
22
908
9019
—
—
—
18
16
878
8852
25
88
814
8176
Skin Pathology biopsy report
65754-4 [40768443]
1.0e+00
2.3e+00
—
1.0e+50
—
2.5e+00
1.2e+00
cases:1.09%
controls:0.40%
cases:0.87%
controls:0.09%
—
—
cases:2.72%
controls:0.00%
—
—
cases:1.56%
controls:0.12%
cases:2.15%
controls:0.63%
10
36
908
9005
8
8
910
9033
—
25
0
893
9041
—
14
11
882
8857
18
52
821
8212
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
2.9e-01
6.8e-01
2.3e+00
—
2.3e+00
7.8e-01
4.5e-01
cases:4.36%
controls:3.29%
cases:3.27%
controls:1.68%
cases:1.63%
controls:0.17%
—
—
cases:2.40%
controls:0.24%
cases:3.91%
controls:1.84%
cases:7.99%
controls:5.24%
40
297
878
8744
30
152
888
8889
15
15
903
9026
—
22
22
896
9009
35
163
861
8705
67
433
772
7831
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
2.0e+00
2.3e+00
—
—
1.0e+50
—
1.7e+00
cases:1.63%
controls:0.22%
cases:0.87%
controls:0.09%
—
—
—
—
cases:0.87%
controls:0.00%
—
—
cases:3.10%
controls:0.57%
15
20
903
9021
8
8
910
9033
—
—
8
0
910
9031
—
26
47
813
8217
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.9e+00
2.4e+00
—
—
1.0e+50
—
1.7e+00
cases:1.53%
controls:0.23%
cases:0.98%
controls:0.09%
—
—
—
—
cases:0.87%
controls:0.00%
—
—
cases:3.22%
controls:0.59%
14
21
904
9020
9
8
909
9033
—
—
8
0
910
9031
—
27
49
812
8215
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
9.0e-01
1.0e+00
1.9e+00
—
—
1.3e+00
7.9e-01
cases:3.05%
controls:1.26%
cases:2.07%
controls:0.74%
cases:0.76%
controls:0.11%
—
—
—
—
cases:2.46%
controls:0.67%
cases:4.05%
controls:1.88%
28
114
890
8927
19
67
899
8974
7
10
911
9031
—
—
22
59
874
8809
34
155
805
8109
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
1.3e+00
1.7e+00
—
—
—
2.0e+00
9.8e-01
cases:1.96%
controls:0.55%
cases:1.20%
controls:0.22%
—
—
—
—
—
—
cases:1.56%
controls:0.21%
cases:2.86%
controls:1.09%
18
50
900
8991
11
20
907
9021
—
—
—
14
19
882
8849
24
90
815
8174
hydrocortisone aceponate
D07AC16 [21602135]
4.4e-01
7.9e-01
2.4e+00
—
1.8e+00
5.4e-01
4.4e-01
cases:9.59%
controls:6.38%
cases:4.25%
controls:1.98%
cases:2.07%
controls:0.19%
—
—
cases:1.53%
controls:0.24%
cases:3.46%
controls:2.05%
cases:9.77%
controls:6.51%
88
577
830
8464
39
179
879
8862
19
17
899
9024
—
14
22
904
9009
31
182
865
8686
82
538
757
7726
hydrocortisone butyrate
D07AB02 [21602106]
4.4e-01
7.9e-01
2.4e+00
—
1.8e+00
5.4e-01
4.4e-01
cases:9.59%
controls:6.38%
cases:4.25%
controls:1.98%
cases:2.07%
controls:0.19%
—
—
cases:1.53%
controls:0.24%
cases:3.46%
controls:2.05%
cases:9.77%
controls:6.51%
88
577
830
8464
39
179
879
8862
19
17
899
9024
—
14
22
904
9009
31
182
865
8686
82
538
757
7726
hydrocortisone
D07AA02 [21602102]
4.4e-01
7.9e-01
2.4e+00
—
1.8e+00
5.4e-01
4.4e-01
cases:9.59%
controls:6.38%
cases:4.25%
controls:1.98%
cases:2.07%
controls:0.19%
—
—
cases:1.53%
controls:0.24%
cases:3.46%
controls:2.05%
cases:9.77%
controls:6.51%
88
577
830
8464
39
179
879
8862
19
17
899
9024
—
14
22
904
9009
31
182
865
8686
82
538
757
7726
hydrocortisone buteprate
D07AB11 [21602115]
4.4e-01
7.9e-01
2.4e+00
—
1.8e+00
5.4e-01
4.4e-01
cases:9.59%
controls:6.38%
cases:4.25%
controls:1.98%
cases:2.07%
controls:0.19%
—
—
cases:1.53%
controls:0.24%
cases:3.46%
controls:2.05%
cases:9.77%
controls:6.51%
88
577
830
8464
39
179
879
8862
19
17
899
9024
—
14
22
904
9009
31
182
865
8686
82
538
757
7726
Short blood count panel - Blood
55429-5 [40758558]
4.8e-01
7.8e-01
1.5e+00
—
2.0e+00
1.0e+00
6.6e-01
cases:5.34%
controls:3.38%
cases:4.03%
controls:1.89%
cases:1.96%
controls:0.44%
—
—
cases:2.83%
controls:0.41%
cases:4.58%
controls:1.68%
cases:7.87%
controls:4.24%
49
306
869
8735
37
171
881
8870
18
40
900
9001
—
26
37
892
8994
41
149
855
8719
66
350
773
7914
Arthritis, unspecified
M13.9 [45567463]
1.2e+00
1.5e+00
—
1.0e+50
—
1.7e+00
1.5e+00
cases:2.07%
controls:0.65%
cases:0.98%
controls:0.21%
—
—
cases:0.87%
controls:0.00%
—
—
cases:1.23%
controls:0.23%
cases:3.22%
controls:0.74%
19
59
899
8982
9
19
909
9022
—
8
0
910
9041
—
11
20
885
8848
27
61
812
8203
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
1.2e+00
2.0e+00
—
—
—
1.6e+00
1.0e+00
cases:2.83%
controls:0.83%
cases:1.53%
controls:0.21%
—
—
—
—
—
—
cases:1.90%
controls:0.37%
cases:3.93%
controls:1.49%
26
75
892
8966
14
19
904
9022
—
—
—
17
33
879
8835
33
123
806
8141
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.6e-01
6.5e-01
1.1e+00
—
2.0e+00
1.0e+00
6.3e-01
cases:15.36%
controls:10.26%
cases:10.46%
controls:5.73%
cases:3.59%
controls:1.24%
—
—
cases:7.95%
controls:1.11%
cases:14.51%
controls:5.90%
cases:22.65%
controls:13.47%
141
928
777
8113
96
518
822
8523
33
112
885
8929
—
73
100
845
8931
130
523
766
8345
190
1113
649
7151
FEV1
20150-9 [3024653]
1.1e+00
1.0e+00
—
—
—
2.3e+00
2.4e+00
cases:3.16%
controls:1.05%
cases:0.98%
controls:0.35%
—
—
—
—
—
—
cases:2.57%
controls:0.26%
cases:4.89%
controls:0.46%
29
95
889
8946
9
32
909
9009
—
—
—
23
23
873
8845
41
38
798
8226
FEV1/FVC
19926-5 [3011505]
1.1e+00
1.0e+00
—
—
—
2.3e+00
2.4e+00
cases:3.16%
controls:1.05%
cases:0.98%
controls:0.35%
—
—
—
—
—
—
cases:2.57%
controls:0.26%
cases:4.89%
controls:0.46%
29
95
889
8946
9
32
909
9009
—
—
—
23
23
873
8845
41
38
798
8226
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.1e+00
1.0e+00
—
—
—
2.3e+00
2.4e+00
cases:3.16%
controls:1.05%
cases:0.98%
controls:0.35%
—
—
—
—
—
—
cases:2.57%
controls:0.26%
cases:4.89%
controls:0.46%
29
95
889
8946
9
32
909
9009
—
—
—
23
23
873
8845
41
38
798
8226
hydrocortisone
A07EA02 [21600654]
4.4e-01
7.7e-01
2.4e+00
—
1.8e+00
5.4e-01
4.2e-01
cases:9.80%
controls:6.55%
cases:4.25%
controls:2.01%
cases:2.07%
controls:0.20%
—
—
cases:1.53%
controls:0.24%
cases:3.57%
controls:2.12%
cases:9.77%
controls:6.63%
90
592
828
8449
39
182
879
8859
19
18
899
9023
—
14
22
904
9009
32
188
864
8680
82
548
757
7716
hydrocortisone
C05AA01 [21601608]
4.4e-01
7.7e-01
2.4e+00
—
1.8e+00
5.4e-01
4.2e-01
cases:9.80%
controls:6.55%
cases:4.25%
controls:2.01%
cases:2.07%
controls:0.20%
—
—
cases:1.53%
controls:0.24%
cases:3.57%
controls:2.12%
cases:9.77%
controls:6.63%
90
592
828
8449
39
182
879
8859
19
18
899
9023
—
14
22
904
9009
32
188
864
8680
82
548
757
7716
budesonide; oral, sublingual
A07EA06 [21600658]
1.6e+00
2.6e+00
—
—
—
1.4e+00
1.6e+00
cases:1.31%
controls:0.27%
cases:1.31%
controls:0.10%
—
—
—
—
—
—
cases:0.67%
controls:0.16%
cases:1.67%
controls:0.33%
12
24
906
9017
12
9
906
9032
—
—
—
6
14
890
8854
14
27
825
8237
Emergency Room and Inpatient Visit
ERIP [262]
7.4e-01
7.6e-01
1.9e+00
—
1.7e+00
7.6e-01
3.8e-01
cases:3.81%
controls:1.86%
cases:2.72%
controls:1.29%
cases:1.20%
controls:0.18%
—
—
cases:1.09%
controls:0.21%
cases:2.79%
controls:1.33%
cases:7.51%
controls:5.24%
35
168
883
8873
25
117
893
8924
11
16
907
9025
—
10
19
908
9012
25
118
871
8750
63
433
776
7831
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.1e+00
9.1e-01
—
—
—
2.4e+00
2.3e+00
cases:2.61%
controls:0.91%
cases:0.76%
controls:0.31%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:3.81%
controls:0.41%
24
82
894
8959
7
28
911
9013
—
—
—
18
16
878
8852
32
34
807
8230
FEV1 percent change
69983-5 [42868472]
1.1e+00
9.1e-01
—
—
—
2.4e+00
2.3e+00
cases:2.61%
controls:0.91%
cases:0.76%
controls:0.31%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:3.81%
controls:0.41%
24
82
894
8959
7
28
911
9013
—
—
—
18
16
878
8852
32
34
807
8230
FVC percent change Respiratory system
69982-7 [42868471]
1.1e+00
9.1e-01
—
—
—
2.4e+00
2.3e+00
cases:2.61%
controls:0.91%
cases:0.76%
controls:0.31%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:3.81%
controls:0.41%
24
82
894
8959
7
28
911
9013
—
—
—
18
16
878
8852
32
34
807
8230
FEV1 --post bronchodilation
20155-8 [3023550]
1.1e+00
9.1e-01
—
—
—
2.4e+00
2.3e+00
cases:2.61%
controls:0.91%
cases:0.76%
controls:0.31%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:3.81%
controls:0.41%
24
82
894
8959
7
28
911
9013
—
—
—
18
16
878
8852
32
34
807
8230
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.1e+00
9.1e-01
—
—
—
2.4e+00
2.3e+00
cases:2.61%
controls:0.91%
cases:0.76%
controls:0.31%
—
—
—
—
—
—
cases:2.01%
controls:0.18%
cases:3.81%
controls:0.41%
24
82
894
8959
7
28
911
9013
—
—
—
18
16
878
8852
32
34
807
8230
phenoxymethylpenicillin; oral
J01CE02 [21602842]
3.2e-01
7.6e-01
2.2e+00
—
2.0e+00
1.2e-01
3.4e-01
cases:16.23%
controls:12.33%
cases:6.86%
controls:3.33%
cases:3.38%
controls:0.39%
—
—
cases:2.18%
controls:0.29%
cases:3.91%
controls:3.48%
cases:17.16%
controls:12.85%
149
1115
769
7926
63
301
855
8740
31
35
887
9006
—
20
26
898
9005
35
309
861
8559
144
1062
695
7202
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
3.2e-01
7.6e-01
2.2e+00
—
2.0e+00
1.2e-01
3.4e-01
cases:16.23%
controls:12.33%
cases:6.86%
controls:3.33%
cases:3.38%
controls:0.39%
—
—
cases:2.18%
controls:0.29%
cases:3.91%
controls:3.48%
cases:17.16%
controls:12.85%
149
1115
769
7926
63
301
855
8740
31
35
887
9006
—
20
26
898
9005
35
309
861
8559
144
1062
695
7202
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
5.6e-01
8.0e-01
2.6e+00
—
2.3e+00
1.1e+00
7.0e-01
cases:2.29%
controls:1.32%
cases:0.76%
controls:0.34%
cases:0.76%
controls:0.06%
—
—
cases:0.76%
controls:0.08%
cases:1.34%
controls:0.45%
cases:3.58%
controls:1.82%
21
119
897
8922
7
31
911
9010
7
5
911
9036
—
7
7
911
9024
12
40
884
8828
30
150
809
8114
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
3.6e-01
1.6e+00
—
—
2.7e+00
1.3e+00
5.8e-01
cases:2.72%
controls:1.91%
cases:3.05%
controls:0.64%
—
—
—
—
cases:1.20%
controls:0.08%
cases:1.67%
controls:0.47%
cases:4.53%
controls:2.58%
25
173
893
8868
28
58
890
8983
—
—
11
7
907
9024
15
42
881
8826
38
213
801
8051
clobetasol
D07AD01 [21602141]
4.6e-01
1.0e+00
—
1.0e+50
2.6e+00
1.2e+00
7.5e-01
cases:2.61%
controls:1.67%
cases:1.63%
controls:0.59%
—
—
cases:0.54%
controls:0.00%
cases:1.31%
controls:0.10%
cases:2.46%
controls:0.73%
cases:4.29%
controls:2.08%
24
151
894
8890
15
53
903
8988
—
5
0
913
9041
12
9
906
9022
22
65
874
8803
36
172
803
8092
Localized oedema
R60.0 [45597193]
8.5e-01
2.4e+00
—
—
—
2.1e+00
9.5e-01
cases:1.42%
controls:0.61%
cases:1.74%
controls:0.15%
—
—
—
—
—
—
cases:1.79%
controls:0.21%
cases:2.50%
controls:0.98%
13
55
905
8986
16
14
902
9027
—
—
—
16
19
880
8849
21
81
818
8183
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.3e+00
1.2e+00
—
1.0e+50
2.6e+00
1.5e+00
7.6e-01
cases:1.63%
controls:0.43%
cases:1.20%
controls:0.38%
—
—
cases:0.65%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.23%
controls:0.27%
cases:2.74%
controls:1.31%
15
39
903
9002
11
34
907
9007
—
6
0
912
9041
7
5
911
9026
11
24
885
8844
23
108
816
8156
pH of Urine
2756-5 [3015736]
2.4e-01
7.2e-01
2.1e+00
—
2.2e+00
4.4e-01
4.7e-01
cases:5.88%
controls:4.68%
cases:5.01%
controls:2.51%
cases:2.72%
controls:0.34%
—
—
cases:3.05%
controls:0.35%
cases:3.91%
controls:2.55%
cases:12.16%
controls:7.95%
54
423
864
8618
46
227
872
8814
25
31
893
9010
—
28
32
890
8999
35
226
861
8642
102
657
737
7607
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.0e-01
4.5e-01
1.7e+00
—
2.0e+00
1.0e+00
7.5e-01
cases:3.81%
controls:2.59%
cases:1.96%
controls:1.26%
cases:0.87%
controls:0.15%
—
—
cases:1.09%
controls:0.16%
cases:3.01%
controls:1.12%
cases:7.87%
controls:3.86%
35
234
883
8807
18
114
900
8927
8
14
910
9027
—
10
14
908
9017
27
99
869
8769
66
319
773
7945
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
1.1e+00
1.4e+00
—
—
—
1.9e+00
1.0e+00
cases:2.61%
controls:0.87%
cases:1.42%
controls:0.37%
—
—
—
—
—
—
cases:2.23%
controls:0.33%
cases:3.93%
controls:1.45%
24
79
894
8962
13
33
905
9008
—
—
—
20
29
876
8839
33
120
806
8144
Outpatient Hospital
22 [8756]
2.8e-01
5.4e-01
1.3e+00
—
2.0e+00
8.2e-01
4.1e-01
cases:25.82%
controls:20.86%
cases:10.13%
controls:6.18%
cases:2.61%
controls:0.72%
—
—
cases:4.90%
controls:0.66%
cases:12.39%
controls:5.85%
cases:24.08%
controls:17.38%
237
1886
681
7155
93
559
825
8482
24
65
894
8976
—
45
60
873
8971
111
519
785
8349
202
1436
637
6828
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.1e+00
9.3e-01
—
—
2.0e+00
1.2e+00
1.1e+00
cases:2.83%
controls:1.01%
cases:1.53%
controls:0.61%
—
—
—
—
cases:0.76%
controls:0.10%
cases:1.90%
controls:0.58%
cases:5.24%
controls:1.85%
26
91
892
8950
14
55
904
8986
—
—
7
9
911
9022
17
51
879
8817
44
153
795
8111
Pharmacy visit
OMOP4822462 [581458]
-4.0e-02
3.3e-01
1.1e+00
2.3e+00
1.2e+00
4.2e-01
1.8e-01
cases:82.90%
controls:83.45%
cases:78.21%
controls:72.07%
cases:60.68%
controls:34.20%
cases:15.03%
controls:1.71%
cases:64.16%
controls:34.53%
cases:80.69%
controls:73.34%
cases:91.42%
controls:89.92%
761
7545
157
1496
718
6516
200
2525
557
3092
361
5949
138
155
780
8886
589
3118
329
5913
723
6504
173
2364
767
7431
72
833
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.6e+00
—
—
—
—
2.6e+00
1.2e+00
cases:1.09%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.67%
controls:0.50%
10
21
908
9020
—
—
—
—
8
6
888
8862
14
41
825
8223
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.9e-01
2.3e-01
2.2e+00
—
2.0e+00
7.4e-01
4.7e-01
cases:4.79%
controls:4.00%
cases:2.72%
controls:2.17%
cases:2.18%
controls:0.25%
—
—
cases:1.85%
controls:0.27%
cases:4.13%
controls:2.02%
cases:9.30%
controls:6.00%
44
362
874
8679
25
196
893
8845
20
23
898
9018
—
17
24
901
9007
37
179
859
8689
78
496
761
7768
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.1e-01
7.6e-01
1.6e+00
—
2.8e+00
1.0e+00
6.6e-01
cases:4.47%
controls:3.01%
cases:2.72%
controls:1.29%
cases:0.65%
controls:0.13%
—
—
cases:2.61%
controls:0.16%
cases:3.79%
controls:1.38%
cases:7.99%
controls:4.31%
41
272
877
8769
25
117
893
8924
6
12
912
9029
—
24
14
894
9017
34
122
862
8746
67
356
772
7908
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
4.9e-01
5.5e-01
2.0e+00
—
3.3e+00
1.3e+00
7.7e-01
cases:3.59%
controls:2.22%
cases:1.74%
controls:1.02%
cases:0.54%
controls:0.08%
—
—
cases:2.29%
controls:0.09%
cases:3.24%
controls:0.95%
cases:6.67%
controls:3.22%
33
201
885
8840
16
92
902
8949
5
7
913
9034
—
21
8
897
9023
29
84
867
8784
56
266
783
7998
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.8e-01
7.9e-01
1.7e+00
—
1.9e+00
5.3e-01
3.9e-01
cases:11.44%
controls:8.89%
cases:10.02%
controls:4.80%
cases:4.03%
controls:0.79%
—
—
cases:4.47%
controls:0.70%
cases:8.04%
controls:4.87%
cases:18.47%
controls:13.25%
105
804
813
8237
92
434
826
8607
37
71
881
8970
—
41
63
877
8968
72
432
824
8436
155
1095
684
7169
combinations of corticosteroids
D07AB30 [21602118]
4.2e-01
6.4e-01
1.4e+00
—
1.6e+00
8.6e-01
3.9e-01
cases:12.96%
controls:8.88%
cases:5.45%
controls:2.94%
cases:1.53%
controls:0.39%
—
—
cases:1.85%
controls:0.39%
cases:6.70%
controls:2.94%
cases:13.47%
controls:9.52%
119
803
799
8238
50
266
868
8775
14
35
904
9006
—
17
35
901
8996
60
261
836
8607
113
787
726
7477
combinations of corticosteroids
D07XB30 [21602188]
4.2e-01
6.4e-01
1.4e+00
—
1.6e+00
8.6e-01
3.9e-01
cases:12.96%
controls:8.88%
cases:5.45%
controls:2.94%
cases:1.53%
controls:0.39%
—
—
cases:1.85%
controls:0.39%
cases:6.70%
controls:2.94%
cases:13.47%
controls:9.52%
119
803
799
8238
50
266
868
8775
14
35
904
9006
—
17
35
901
8996
60
261
836
8607
113
787
726
7477
Nephrology
39 [38004479]
1.3e+00
1.4e+00
1.5e+00
—
1.6e+00
1.5e+00
1.0e+00
cases:1.96%
controls:0.53%
cases:1.74%
controls:0.45%
cases:0.76%
controls:0.18%
—
—
cases:0.76%
controls:0.16%
cases:1.90%
controls:0.42%
cases:2.38%
controls:0.87%
18
48
900
8993
16
41
902
9000
7
16
911
9025
—
7
14
911
9017
17
37
879
8831
20
72
819
8192
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
1.6e+00
—
—
—
3.2e+00
2.0e+00
cases:0.65%
controls:0.23%
cases:0.54%
controls:0.11%
—
—
—
—
—
—
cases:1.34%
controls:0.06%
cases:2.03%
controls:0.27%
6
21
912
9020
5
10
913
9031
—
—
—
12
5
884
8863
17
22
822
8242
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
1.0e+00
8.7e-01
—
—
2.1e+00
1.1e+00
1.0e+00
cases:2.72%
controls:1.02%
cases:1.53%
controls:0.64%
—
—
—
—
cases:0.87%
controls:0.11%
cases:1.79%
controls:0.61%
cases:5.48%
controls:2.06%
25
92
893
8949
14
58
904
8983
—
—
8
10
910
9021
16
54
880
8814
46
170
793
8094
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.5e+00
1.1e+00
—
—
—
2.1e+00
1.6e+00
cases:3.38%
controls:0.76%
cases:1.09%
controls:0.37%
—
—
—
—
—
—
cases:2.23%
controls:0.28%
cases:4.17%
controls:0.91%
31
69
887
8972
10
33
908
9008
—
—
—
20
25
876
8843
35
75
804
8189
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.2e+00
7.7e-01
—
—
2.0e+00
1.1e+00
9.2e-01
cases:3.49%
controls:1.11%
cases:1.42%
controls:0.66%
—
—
—
—
cases:0.87%
controls:0.12%
cases:1.79%
controls:0.61%
cases:5.72%
controls:2.37%
32
100
886
8941
13
60
905
8981
—
—
8
11
910
9020
16
54
880
8814
48
196
791
8068
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
4.3e-01
7.3e-01
1.1e+00
—
2.0e+00
8.7e-01
3.9e-01
cases:7.08%
controls:4.70%
cases:5.77%
controls:2.88%
cases:1.42%
controls:0.48%
—
—
cases:2.29%
controls:0.32%
cases:6.92%
controls:3.02%
cases:13.95%
controls:9.87%
65
425
853
8616
53
260
865
8781
13
43
905
8998
—
21
29
897
9002
62
268
834
8600
117
816
722
7448
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
—
2.5e+00
—
—
—
—
2.6e+00
—
—
cases:0.65%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.07%
—
6
5
912
9036
—
—
—
—
8
6
831
8258
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
3.2e-01
1.2e+00
1.7e+00
—
2.1e+00
3.0e-01
4.8e-01
cases:3.05%
controls:2.23%
cases:2.61%
controls:0.81%
cases:0.87%
controls:0.15%
—
—
cases:1.20%
controls:0.14%
cases:1.45%
controls:1.08%
cases:4.89%
controls:3.07%
28
202
890
8839
24
73
894
8968
8
14
910
9027
—
11
13
907
9018
13
96
883
8772
41
254
798
8010
Medical doctor
Z2221 [2001311556]
4.3e-01
9.8e-01
2.0e+00
1.0e+50
—
1.1e+00
9.0e-01
cases:5.45%
controls:3.62%
cases:2.94%
controls:1.13%
cases:0.76%
controls:0.10%
cases:1.09%
controls:0.00%
—
—
cases:2.79%
controls:0.94%
cases:5.60%
controls:2.35%
50
327
868
8714
27
102
891
8939
7
9
911
9032
10
0
908
9041
—
25
83
871
8785
47
194
792
8070
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.3e+00
1.1e+00
—
—
2.6e+00
1.2e+00
1.1e+00
cases:1.85%
controls:0.51%
cases:0.76%
controls:0.27%
—
—
—
—
cases:0.87%
controls:0.07%
cases:1.00%
controls:0.29%
cases:2.50%
controls:0.83%
17
46
901
8995
7
24
911
9017
—
—
8
6
910
9025
9
26
887
8842
21
69
818
8195
Gas panel - Venous blood
24339-4 [3000991]
1.1e+00
1.3e+00
—
—
—
1.7e+00
8.3e-01
cases:1.42%
controls:0.46%
cases:1.31%
controls:0.35%
—
—
—
—
—
—
cases:1.45%
controls:0.27%
cases:2.62%
controls:1.16%
13
42
905
8999
12
32
906
9009
—
—
—
13
24
883
8844
22
96
817
8168
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
8.6e-01
1.1e+00
1.6e+00
1.0e+50
2.3e+00
8.4e-01
6.4e-01
cases:2.51%
controls:1.07%
cases:1.96%
controls:0.63%
cases:0.54%
controls:0.11%
cases:1.31%
controls:0.00%
cases:0.65%
controls:0.07%
cases:1.45%
controls:0.63%
cases:4.77%
controls:2.57%
23
97
895
8944
18
57
900
8984
5
10
913
9031
12
0
906
9041
6
6
912
9025
13
56
883
8812
40
212
799
8052
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.2e+00
1.3e+00
—
—
1.8e+00
1.5e+00
9.9e-01
cases:2.07%
controls:0.65%
cases:1.96%
controls:0.55%
—
—
—
—
cases:0.54%
controls:0.09%
cases:2.01%
controls:0.45%
cases:2.74%
controls:1.04%
19
59
899
8982
18
50
900
8991
—
—
5
8
913
9023
18
40
878
8828
23
86
816
8178
Case Management Agency
251B00000X [38004193]
1.2e-01
1.9e-01
7.6e-01
3.3e+00
6.5e-01
2.5e-01
6.8e-02
cases:46.84%
controls:43.76%
cases:41.61%
controls:37.04%
cases:26.91%
controls:14.64%
cases:20.59%
controls:0.97%
cases:24.84%
controls:14.75%
cases:45.31%
controls:39.32%
cases:57.09%
controls:55.41%
430
3956
488
5085
382
3349
536
5692
247
1324
671
7717
189
88
729
8953
228
1332
690
7699
406
3487
490
5381
479
4579
360
3685
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
1.2e+00
7.2e-01
—
1.0e+50
—
2.0e+00
1.7e+00
cases:2.07%
controls:0.62%
cases:0.54%
controls:0.27%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.45%
controls:0.20%
cases:2.86%
controls:0.53%
19
56
899
8985
5
24
913
9017
—
6
0
912
9041
—
13
18
883
8850
24
44
815
8220
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
9.2e-01
1.1e+00
1.7e+00
1.0e+50
2.3e+00
7.7e-01
6.2e-01
cases:2.40%
controls:0.97%
cases:1.96%
controls:0.67%
cases:0.54%
controls:0.10%
cases:1.42%
controls:0.00%
cases:0.65%
controls:0.07%
cases:1.45%
controls:0.68%
cases:5.13%
controls:2.83%
22
88
896
8953
18
61
900
8980
5
9
913
9032
13
0
905
9041
6
6
912
9025
13
60
883
8808
43
234
796
8030
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.4e+00
1.8e+00
—
—
—
1.1e+00
1.7e+00
cases:1.74%
controls:0.44%
cases:1.09%
controls:0.19%
—
—
—
—
—
—
cases:0.67%
controls:0.23%
cases:1.91%
controls:0.36%
16
40
902
9001
10
17
908
9024
—
—
—
6
20
890
8848
16
30
823
8234
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.1e-01
8.7e-01
1.7e+00
—
1.5e+00
7.7e-01
3.4e-01
cases:5.12%
controls:3.46%
cases:3.81%
controls:1.63%
cases:1.20%
controls:0.22%
—
—
cases:1.09%
controls:0.25%
cases:4.24%
controls:2.02%
cases:7.99%
controls:5.82%
47
313
871
8728
35
147
883
8894
11
20
907
9021
—
10
23
908
9008
38
179
858
8689
67
481
772
7783
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-9.7e-01
-2.8e-02
—
—
3.2e+00
3.6e+00
cases:11.98%
controls:28.26%
cases:3.70%
controls:9.21%
cases:0.87%
controls:0.90%
—
—
—
—
cases:5.92%
controls:0.26%
cases:14.90%
controls:0.46%
110
2555
808
6486
34
833
884
8208
8
81
910
8960
—
—
53
23
843
8845
125
38
714
8226
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.2e-01
6.2e-01
2.3e+00
1.0e+50
2.4e+00
1.5e+00
8.3e-01
cases:2.07%
controls:1.02%
cases:0.98%
controls:0.53%
cases:0.54%
controls:0.06%
cases:1.53%
controls:0.00%
cases:0.87%
controls:0.08%
cases:1.79%
controls:0.41%
cases:5.01%
controls:2.25%
19
92
899
8949
9
48
909
8993
5
5
913
9036
14
0
904
9041
8
7
910
9024
16
36
880
8832
42
186
797
8078
methotrexate
L01BA01 [21601423]
1.1e+00
9.0e-01
1.1e+00
—
9.7e-01
1.3e+00
1.4e+00
cases:3.59%
controls:1.28%
cases:2.29%
controls:0.94%
cases:0.65%
controls:0.21%
—
—
cases:0.87%
controls:0.33%
cases:3.46%
controls:0.92%
cases:5.36%
controls:1.32%
33
116
885
8925
21
85
897
8956
6
19
912
9022
—
8
30
910
9001
31
82
865
8786
45
109
794
8155
methotrexate; oral, parenteral
L04AX03 [21603929]
1.1e+00
9.0e-01
1.1e+00
—
9.7e-01
1.3e+00
1.4e+00
cases:3.59%
controls:1.28%
cases:2.29%
controls:0.94%
cases:0.65%
controls:0.21%
—
—
cases:0.87%
controls:0.33%
cases:3.46%
controls:0.92%
cases:5.36%
controls:1.32%
33
116
885
8925
21
85
897
8956
6
19
912
9022
—
8
30
910
9001
31
82
865
8786
45
109
794
8155
Cells panel - Urine sediment
58434-2 [40761535]
4.6e-01
9.3e-01
—
—
2.4e+00
1.1e+00
1.1e+00
cases:1.63%
controls:1.04%
cases:1.31%
controls:0.52%
—
—
—
—
cases:0.76%
controls:0.07%
cases:1.45%
controls:0.47%
cases:3.22%
controls:1.06%
15
94
903
8947
12
47
906
8994
—
—
7
6
911
9025
13
42
883
8826
27
88
812
8176
Pain in limb
M79.6 [45587063]
3.4e-01
1.0e+00
2.0e+00
—
—
9.6e-01
6.5e-01
cases:4.90%
controls:3.54%
cases:4.14%
controls:1.50%
cases:1.53%
controls:0.20%
—
—
—
—
cases:3.68%
controls:1.44%
cases:10.85%
controls:5.95%
45
320
873
8721
38
136
880
8905
14
18
904
9023
—
—
33
128
863
8740
91
492
748
7772
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
3.2e-01
8.1e-01
1.7e+00
—
2.2e+00
5.3e-01
4.5e-01
cases:3.16%
controls:2.31%
cases:3.38%
controls:1.53%
cases:1.42%
controls:0.27%
—
—
cases:1.96%
controls:0.22%
cases:2.46%
controls:1.45%
cases:7.39%
controls:4.83%
29
209
889
8832
31
138
887
8903
13
24
905
9017
—
18
20
900
9011
22
129
874
8739
62
399
777
7865
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
—
—
—
—
1.0e+50
2.6e+00
2.0e+00
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.00%
cases:0.89%
controls:0.07%
cases:1.19%
controls:0.16%
—
—
—
—
9
0
909
9031
8
6
888
8862
10
13
829
8251
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.1e+00
1.2e+00
1.0e+00
—
1.8e+00
1.5e+00
8.1e-01
cases:3.59%
controls:1.21%
cases:2.61%
controls:0.79%
cases:0.65%
controls:0.23%
—
—
cases:0.76%
controls:0.13%
cases:2.90%
controls:0.69%
cases:4.05%
controls:1.84%
33
109
885
8932
24
71
894
8970
6
21
912
9020
—
7
12
911
9019
26
61
870
8807
34
152
805
8112
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.1e+00
—
—
—
—
2.5e+00
2.2e+00
cases:0.54%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.07%
cases:1.55%
controls:0.18%
5
16
913
9025
—
—
—
—
7
6
889
8862
13
15
826
8249
General Surgery
2 [38004447]
3.1e-01
4.9e-01
1.6e+00
—
1.2e+00
5.2e-01
5.3e-01
cases:20.59%
controls:16.03%
cases:7.84%
controls:4.97%
cases:2.83%
controls:0.61%
—
—
cases:2.40%
controls:0.74%
cases:7.81%
controls:4.78%
cases:22.17%
controls:14.39%
189
1449
729
7592
72
449
846
8592
26
55
892
8986
—
22
67
896
8964
70
424
826
8444
186
1189
653
7075
Seronegative rheumatoid arthritis
M06.0 [45577103]
1.5e+00
2.3e+00
—
1.0e+50
—
2.3e+00
1.2e+00
cases:0.87%
controls:0.19%
cases:0.76%
controls:0.08%
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.78%
controls:0.08%
cases:0.72%
controls:0.22%
8
17
910
9024
7
7
911
9034
—
5
0
913
9041
—
7
7
889
8861
6
18
833
8246
doxycycline; oral, parenteral
J01AA02 [21602800]
4.3e-01
6.2e-01
1.6e+00
—
1.4e+00
4.2e-01
4.9e-01
cases:23.86%
controls:16.98%
cases:8.82%
controls:4.93%
cases:2.72%
controls:0.54%
—
—
cases:2.29%
controls:0.58%
cases:7.25%
controls:4.91%
cases:23.96%
controls:16.12%
219
1535
699
7506
81
446
837
8595
25
49
893
8992
—
21
52
897
8979
65
435
831
8433
201
1332
638
6932
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
5.8e-01
7.2e-01
1.7e+00
—
1.8e+00
1.1e+00
4.5e-01
cases:4.25%
controls:2.43%
cases:2.29%
controls:1.13%
cases:1.09%
controls:0.21%
—
—
cases:1.20%
controls:0.20%
cases:3.57%
controls:1.20%
cases:6.32%
controls:4.13%
39
220
879
8821
21
102
897
8939
10
19
908
9022
—
11
18
907
9013
32
106
864
8762
53
341
786
7923
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
1.3e+00
2.5e+00
—
—
—
—
2.1e+00
cases:0.87%
controls:0.24%
cases:0.65%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.13%
8
22
910
9019
6
5
912
9036
—
—
—
—
9
11
830
8253
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.3e+00
7.6e-01
—
—
—
1.7e+00
1.5e+00
cases:2.40%
controls:0.65%
cases:0.54%
controls:0.25%
—
—
—
—
—
—
cases:0.89%
controls:0.16%
cases:3.10%
controls:0.70%
22
59
896
8982
5
23
913
9018
—
—
—
8
14
888
8854
26
58
813
8206
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
7.8e-01
1.2e+00
—
—
—
1.6e+00
9.3e-01
cases:3.16%
controls:1.47%
cases:1.74%
controls:0.54%
—
—
—
—
—
—
cases:2.90%
controls:0.59%
cases:4.53%
controls:1.84%
29
133
889
8908
16
49
902
8992
—
—
—
26
52
870
8816
38
152
801
8112
Bacteria identified in Isolate by Culture
43409-2 [3042936]
9.3e-01
8.7e-01
—
—
2.4e+00
1.1e+00
1.1e+00
cases:2.40%
controls:0.96%
cases:1.31%
controls:0.55%
—
—
—
—
cases:1.09%
controls:0.10%
cases:1.12%
controls:0.38%
cases:4.65%
controls:1.52%
22
87
896
8954
12
50
906
8991
—
—
10
9
908
9022
10
34
886
8834
39
126
800
8138
Neutrophils [#/volume] in Blood
26499-4 [3017732]
-6.4e-02
9.4e-01
2.2e+00
—
2.3e+00
6.9e-01
5.4e-01
cases:0.65%
controls:0.70%
cases:0.98%
controls:0.39%
cases:0.87%
controls:0.10%
—
—
cases:0.76%
controls:0.08%
cases:0.89%
controls:0.45%
cases:3.10%
controls:1.83%
6
63
912
8978
9
35
909
9006
8
9
910
9032
—
7
7
911
9024
8
40
888
8828
26
151
813
8113
Pain in joint
M25.5 [45586941]
5.4e-01
3.9e-01
2.8e+00
—
1.5e+00
9.8e-01
7.3e-01
cases:4.68%
controls:2.78%
cases:1.63%
controls:1.12%
cases:1.20%
controls:0.08%
—
—
cases:0.76%
controls:0.18%
cases:2.90%
controls:1.11%
cases:8.46%
controls:4.27%
43
251
875
8790
15
101
903
8940
11
7
907
9034
—
7
16
911
9015
26
98
870
8770
71
353
768
7911
General Practice
1 [38004446]
4.8e-01
4.5e-01
2.0e+00
—
1.3e+00
5.5e-01
2.8e-01
cases:12.20%
controls:7.94%
cases:4.68%
controls:3.03%
cases:2.94%
controls:0.42%
—
—
cases:1.63%
controls:0.43%
cases:5.80%
controls:3.43%
cases:12.40%
controls:9.63%
112
718
806
8323
43
274
875
8767
27
38
891
9003
—
15
39
903
8992
52
304
844
8564
104
796
735
7468
calcium (different salts in combination); oral
A12AA20 [21600872]
6.4e-01
6.3e-01
5.0e-01
—
1.2e+00
9.7e-01
8.7e-01
cases:9.59%
controls:5.31%
cases:7.08%
controls:3.92%
cases:1.53%
controls:0.93%
—
—
cases:3.05%
controls:0.93%
cases:9.38%
controls:3.79%
cases:15.02%
controls:6.87%
88
480
830
8561
65
354
853
8687
14
84
904
8957
—
28
84
890
8947
84
336
812
8532
126
568
713
7696
Other specified special examinations
Z01.8 [45581003]
3.9e-01
4.3e-01
—
—
2.3e+00
1.2e+00
7.9e-01
cases:2.61%
controls:1.78%
cases:0.98%
controls:0.64%
—
—
—
—
cases:0.76%
controls:0.08%
cases:2.01%
controls:0.60%
cases:5.01%
controls:2.34%
24
161
894
8880
9
58
909
8983
—
—
7
7
911
9024
18
53
878
8815
42
193
797
8071
Other and unspecified abdominal pain
R10.4 [45568113]
6.1e-01
6.5e-01
2.1e+00
—
6.8e-01
9.5e-01
6.5e-01
cases:7.63%
controls:4.29%
cases:2.51%
controls:1.33%
cases:0.87%
controls:0.11%
—
—
cases:0.54%
controls:0.28%
cases:3.46%
controls:1.36%
cases:9.89%
controls:5.42%
70
388
848
8653
23
120
895
8921
8
10
910
9031
—
5
25
913
9006
31
121
865
8747
83
448
756
7816
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2.0e+00
—
—
—
—
2.3e+00
4.3e-01
cases:0.87%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.09%
cases:0.60%
controls:0.39%
8
11
910
9030
—
—
—
—
8
8
888
8860
5
32
834
8232
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.7e-01
5.5e-01
2.2e+00
—
2.1e+00
2.0e-01
3.2e-01
cases:3.16%
controls:2.20%
cases:2.29%
controls:1.33%
cases:1.42%
controls:0.17%
—
—
cases:1.63%
controls:0.20%
cases:1.79%
controls:1.47%
cases:7.27%
controls:5.37%
29
199
889
8842
21
120
897
8921
13
15
905
9026
—
15
18
903
9013
16
130
880
8738
61
444
778
7820
INR in Blood by Coagulation assay
34714-6 [3032080]
5.8e-01
5.1e-01
1.1e+00
—
1.4e+00
6.4e-01
5.6e-01
cases:7.73%
controls:4.49%
cases:4.58%
controls:2.80%
cases:2.40%
controls:0.84%
—
—
cases:2.94%
controls:0.73%
cases:4.91%
controls:2.65%
cases:10.97%
controls:6.57%
71
406
847
8635
42
253
876
8788
22
76
896
8965
—
27
66
891
8965
44
235
852
8633
92
543
747
7721
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
—
—
—
—
1.0e+50
2.6e+00
1.6e+00
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.00%
cases:0.78%
controls:0.06%
cases:1.19%
controls:0.24%
—
—
—
—
10
0
908
9031
7
5
889
8863
10
20
829
8244
metronidazole; oral, rectal
P01AB01 [21604857]
4.0e-01
7.9e-01
1.0e+00
—
1.8e+00
1.1e+00
5.4e-01
cases:8.93%
controls:6.19%
cases:3.59%
controls:1.67%
cases:0.65%
controls:0.23%
—
—
cases:1.31%
controls:0.21%
cases:4.35%
controls:1.54%
cases:10.37%
controls:6.29%
82
560
836
8481
33
151
885
8890
6
21
912
9020
—
12
19
906
9012
39
137
857
8731
87
520
752
7744
Colonoscopy Study observation
28023-0 [3022145]
6.4e-01
1.3e+00
—
—
—
1.9e+00
1.1e+00
cases:1.85%
controls:0.98%
cases:1.63%
controls:0.45%
—
—
—
—
—
—
cases:1.67%
controls:0.26%
cases:3.69%
controls:1.32%
17
89
901
8952
15
41
903
9000
—
—
—
15
23
881
8845
31
109
808
8155
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
4.9e-01
6.3e-01
1.8e+00
—
1.8e+00
5.7e-01
5.5e-01
cases:4.90%
controls:3.05%
cases:2.61%
controls:1.42%
cases:1.09%
controls:0.18%
—
—
cases:1.09%
controls:0.18%
cases:2.46%
controls:1.41%
cases:8.22%
controls:4.94%
45
276
873
8765
24
128
894
8913
10
16
908
9025
—
10
16
908
9015
22
125
874
8743
69
408
770
7856
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
—
—
—
—
1.0e+50
2.6e+00
1.6e+00
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.00%
cases:0.78%
controls:0.06%
cases:1.19%
controls:0.25%
—
—
—
—
10
0
908
9031
7
5
889
8863
10
21
829
8243
Inpatient Visit
IP [9201]
2.9e-01
6.5e-01
9.1e-01
—
2.2e+00
8.9e-01
4.7e-01
cases:9.80%
controls:7.54%
cases:4.90%
controls:2.62%
cases:0.87%
controls:0.35%
—
—
cases:2.29%
controls:0.27%
cases:5.92%
controls:2.53%
cases:11.44%
controls:7.45%
90
682
828
8359
45
237
873
8804
8
32
910
9009
—
21
24
897
9007
53
224
843
8644
96
616
743
7648
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
4.0e-01
5.5e-01
2.5e+00
—
1.7e+00
4.6e-01
1.5e-01
cases:6.97%
controls:4.77%
cases:2.29%
controls:1.33%
cases:1.09%
controls:0.09%
—
—
cases:1.09%
controls:0.21%
cases:2.01%
controls:1.27%
cases:5.01%
controls:4.32%
64
431
854
8610
21
120
897
8921
10
8
908
9033
—
10
19
908
9012
18
113
878
8755
42
357
797
7907
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
1.1e+00
1.3e+00
—
—
—
1.7e+00
1.3e+00
cases:1.74%
controls:0.59%
cases:0.65%
controls:0.19%
—
—
—
—
—
—
cases:1.00%
controls:0.18%
cases:1.79%
controls:0.47%
16
53
902
8988
6
17
912
9024
—
—
—
9
16
887
8852
15
39
824
8225
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
I80.0 [45576919]
1.1e+00
—
—
—
—
2.5e+00
1.7e+00
cases:0.76%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.06%
cases:1.07%
controls:0.21%
7
24
911
9017
—
—
—
—
6
5
890
8863
9
17
830
8247
Foot/toe symptom/complaint
L17 [2002000641]
4.9e-01
1.2e+00
2.3e+00
—
—
-3.3e-01
6.4e-01
cases:4.03%
controls:2.51%
cases:2.94%
controls:0.91%
cases:1.09%
controls:0.11%
—
—
—
—
cases:0.67%
controls:0.92%
cases:6.67%
controls:3.62%
37
227
881
8814
27
82
891
8959
10
10
908
9031
—
—
6
82
890
8786
56
299
783
7965
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.9e-01
4.0e-01
1.3e+00
—
1.7e+00
6.8e-01
3.8e-01
cases:8.93%
controls:6.25%
cases:5.23%
controls:3.56%
cases:2.18%
controls:0.58%
—
—
cases:2.18%
controls:0.40%
cases:6.36%
controls:3.32%
cases:14.18%
controls:10.15%
82
565
836
8476
48
322
870
8719
20
52
898
8989
—
20
36
898
8995
57
294
839
8574
119
839
720
7425
Chronic ulcer skin
S97 [2002001061]
—
—
—
—
—
2.6e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.55%
controls:0.34%
—
—
—
—
—
8
6
888
8862
13
28
826
8236
furosemide; oral, parenteral
C03CA01 [21601518]
8.5e-01
6.9e-01
1.1e+00
—
4.1e-01
8.0e-01
6.3e-01
cases:6.10%
controls:2.70%
cases:4.68%
controls:2.40%
cases:1.96%
controls:0.65%
—
—
cases:0.98%
controls:0.65%
cases:5.02%
controls:2.31%
cases:7.51%
controls:4.13%
56
244
862
8797
43
217
875
8824
18
59
900
8982
—
9
59
909
8972
45
205
851
8663
63
341
776
7923
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 [40769539]
2.4e+00
—
—
—
—
—
1.6e+00
cases:0.76%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.22%
7
6
911
9035
—
—
—
—
—
9
18
830
8246
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
4.8e-01
7.2e-01
1.2e+00
—
1.9e+00
9.3e-01
5.2e-01
cases:5.34%
controls:3.36%
cases:3.27%
controls:1.61%
cases:1.20%
controls:0.37%
—
—
cases:1.63%
controls:0.25%
cases:4.13%
controls:1.67%
cases:7.99%
controls:4.89%
49
304
869
8737
30
146
888
8895
11
33
907
9008
—
15
23
903
9008
37
148
859
8720
67
404
772
7860
Paranasal sinuses X-ray examination without contrast
DM1AA [2001301740]
1.5e+00
—
—
—
—
2.5e+00
1.0e+00
cases:1.20%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.06%
cases:0.60%
controls:0.22%
11
24
907
9017
—
—
—
—
6
5
890
8863
5
18
834
8246
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
—
—
—
—
—
2.1e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:0.83%
controls:0.13%
—
—
—
—
—
6
7
890
8861
7
11
832
8253
Otolaryngology
4 [38004449]
5.5e-01
6.1e-01
1.2e+00
—
1.4e+00
9.4e-01
4.6e-01
cases:13.40%
controls:8.17%
cases:5.56%
controls:3.10%
cases:0.98%
controls:0.29%
—
—
cases:1.74%
controls:0.43%
cases:7.03%
controls:2.86%
cases:14.30%
controls:9.54%
123
739
795
8302
51
280
867
8761
9
26
909
9015
—
16
39
902
8992
63
254
833
8614
120
788
719
7476
Upper gastrointestinal surgery
106 [44777669]
5.1e-01
8.2e-01
1.2e+00
—
1.3e+00
7.5e-01
5.7e-01
cases:8.93%
controls:5.59%
cases:4.68%
controls:2.11%
cases:0.98%
controls:0.29%
—
—
cases:1.31%
controls:0.37%
cases:4.13%
controls:1.98%
cases:10.97%
controls:6.53%
82
505
836
8536
43
191
875
8850
9
26
909
9015
—
12
33
906
8998
37
176
859
8692
92
540
747
7724
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
6.8e-01
2.1e+00
—
—
1.0e+50
1.9e+00
3.6e-01
cases:1.31%
controls:0.66%
cases:1.20%
controls:0.15%
—
—
—
—
cases:0.87%
controls:0.00%
cases:1.45%
controls:0.23%
cases:1.43%
controls:1.00%
12
60
906
8981
11
14
907
9027
—
—
8
0
910
9031
13
20
883
8848
12
83
827
8181
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
—
1.9e+00
1.0e+50
1.0e+50
1.0e+50
2.3e+00
1.6e+00
—
—
cases:0.65%
controls:0.10%
cases:0.87%
controls:0.00%
cases:0.65%
controls:0.00%
cases:1.20%
controls:0.00%
cases:0.67%
controls:0.07%
cases:1.07%
controls:0.22%
—
6
9
912
9032
8
0
910
9041
6
0
912
9041
11
0
907
9031
6
6
890
8862
9
18
830
8246
leflunomide; oral
L04AK01 [955035]
2.1e+00
—
—
—
—
—
1.7e+00
cases:1.09%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.17%
10
12
908
9029
—
—
—
—
—
8
14
831
8250
Sampling
SPAT1263 [2001700364]
3.8e-01
6.7e-01
2.0e+00
—
1.1e+00
7.1e-01
4.2e-01
cases:8.06%
controls:5.66%
cases:4.47%
controls:2.34%
cases:2.29%
controls:0.31%
—
—
cases:0.98%
controls:0.33%
cases:4.69%
controls:2.36%
cases:10.25%
controls:6.96%
74
512
844
8529
41
212
877
8829
21
28
897
9013
—
9
30
909
9001
42
209
854
8659
86
575
753
7689
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
1.1e+00
1.3e+00
2.1e+00
—
—
1.3e+00
2.7e-01
cases:1.96%
controls:0.63%
cases:1.63%
controls:0.43%
cases:0.54%
controls:0.07%
—
—
—
—
cases:1.34%
controls:0.36%
cases:1.67%
controls:1.28%
18
57
900
8984
15
39
903
9002
5
6
913
9035
—
—
12
32
884
8836
14
106
825
8158
Acute and subacute iridocyclitis
H20.0 [45542994]
1.6e+00
—
—
—
—
2.2e+00
6.5e-01
cases:1.31%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:0.83%
controls:0.44%
12
24
906
9017
—
—
—
—
8
9
888
8859
7
36
832
8228
adalimumab; parenteral
L04AB04 [21603911]
1.7e+00
1.3e+00
—
—
—
1.7e+00
2.1e+00
cases:0.98%
controls:0.18%
cases:0.54%
controls:0.15%
—
—
—
—
—
—
cases:0.67%
controls:0.12%
cases:1.31%
controls:0.17%
9
16
909
9025
5
14
913
9027
—
—
—
6
11
890
8857
11
14
828
8250
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.1e+00
—
—
—
—
2.2e+00
1.6e+00
cases:0.87%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.55%
controls:0.33%
8
27
910
9014
—
—
—
—
8
9
888
8859
13
27
826
8237
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
6.7e-01
2.0e+00
—
—
1.0e+50
1.7e+00
1.8e-01
cases:1.20%
controls:0.62%
cases:1.09%
controls:0.14%
—
—
—
—
cases:0.87%
controls:0.00%
cases:1.23%
controls:0.23%
cases:1.07%
controls:0.90%
11
56
907
8985
10
13
908
9028
—
—
8
0
910
9031
11
20
885
8848
9
74
830
8190
Specific gravity of Urine by Refractometry
5810-7 [3019150]
3.3e-01
6.3e-01
1.6e+00
—
2.1e+00
6.3e-01
3.7e-01
cases:4.03%
controls:2.92%
cases:3.27%
controls:1.77%
cases:1.20%
controls:0.25%
—
—
cases:1.96%
controls:0.23%
cases:3.24%
controls:1.75%
cases:7.15%
controls:5.06%
37
264
881
8777
30
160
888
8881
11
23
907
9018
—
18
21
900
9010
29
155
867
8713
60
418
779
7846
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
9.6e-01
1.4e+00
—
—
—
5.4e-01
1.3e+00
cases:1.96%
controls:0.76%
cases:1.31%
controls:0.32%
—
—
—
—
—
—
cases:0.56%
controls:0.33%
cases:2.98%
controls:0.81%
18
69
900
8972
12
29
906
9012
—
—
—
5
29
891
8839
25
67
814
8197
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.3e+00
2.1e+00
—
—
—
—
1.6e+00
cases:0.54%
controls:0.14%
cases:0.65%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.25%
5
13
913
9028
6
7
912
9034
—
—
—
—
10
21
829
8243
Osmolality of Urine
2695-5 [3026782]
5.5e-01
7.2e-01
1.3e+00
1.0e+50
2.9e+00
8.5e-01
7.9e-01
cases:3.49%
controls:2.04%
cases:1.96%
controls:0.96%
cases:0.54%
controls:0.14%
cases:1.42%
controls:0.00%
cases:1.53%
controls:0.09%
cases:2.01%
controls:0.87%
cases:5.48%
controls:2.58%
32
184
886
8857
18
87
900
8954
5
13
913
9028
13
0
905
9041
14
8
904
9023
18
77
878
8791
46
213
793
8051
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
313 [2001600274]
2.0e+00
—
—
—
—
—
1.6e+00
cases:1.09%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.95%
controls:0.19%
10
13
908
9028
—
—
—
—
—
8
16
831
8248
Abdominal ultrasound examination
JN3AE [2001305555]
9.0e-01
1.3e+00
—
1.0e+50
—
1.5e+00
1.2e+00
cases:2.83%
controls:1.17%
cases:1.09%
controls:0.29%
—
—
cases:0.76%
controls:0.00%
—
—
cases:1.56%
controls:0.36%
cases:3.81%
controls:1.14%
26
106
892
8935
10
26
908
9015
—
7
0
911
9041
—
14
32
882
8836
32
94
807
8170
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
8.0e-01
2.3e+00
1.0e+50
1.0e+50
—
1.6e+00
1.3e+00
cases:0.76%
controls:0.34%
cases:1.42%
controls:0.14%
cases:1.31%
controls:0.00%
cases:1.09%
controls:0.00%
—
—
cases:0.67%
controls:0.14%
cases:1.91%
controls:0.52%
7
31
911
9010
13
13
905
9028
12
0
906
9041
10
0
908
9041
—
6
12
890
8856
16
43
823
8221
Bone marrow biopsy
XW000 [2001310618]
2.0e+00
—
—
—
—
—
1.6e+00
cases:0.98%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.22%
9
12
909
9029
—
—
—
—
—
9
18
830
8246
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.9e-01
8.2e-01
1.2e+00
—
1.5e+00
8.4e-01
4.1e-01
cases:8.06%
controls:5.11%
cases:4.25%
controls:1.92%
cases:1.31%
controls:0.41%
—
—
cases:1.09%
controls:0.25%
cases:3.79%
controls:1.67%
cases:7.75%
controls:5.26%
74
462
844
8579
39
174
879
8867
12
37
906
9004
—
10
23
908
9008
34
148
862
8720
65
435
774
7829
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
chlorhexidine
S02AA09 [21605155]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
chlorhexidine
S03AA04 [21605193]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
hydrocortisone
D07XA01 [21602180]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
chlorhexidine
D09AA12 [21602275]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
chlorhexidine, combinations
D08AC52 [21602208]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
hydrocortisone and antiseptics
D07BA04 [21602146]
5.9e-01
1.2e+00
2.4e+00
—
1.5e+00
9.1e-01
4.0e-01
cases:3.27%
controls:1.84%
cases:1.53%
controls:0.49%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.54%
cases:2.50%
controls:1.69%
30
166
888
8875
14
44
904
8997
7
6
911
9035
—
5
11
913
9020
12
48
884
8820
21
140
818
8124
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.4e+00
—
—
—
—
2.1e+00
1.3e+00
cases:1.20%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.19%
controls:0.34%
11
26
907
9015
—
—
—
—
6
7
890
8861
10
28
829
8236
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
1.2e+00
2.3e+00
—
—
—
—
1.3e+00
cases:0.54%
controls:0.17%
cases:0.65%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.40%
5
15
913
9026
6
6
912
9035
—
—
—
—
12
33
827
8231
Essential (primary) hypertension
I10 [45591453]
3.1e-01
3.2e-01
1.1e+00
—
1.8e+00
7.3e-01
2.8e-01
cases:11.00%
controls:8.35%
cases:5.88%
controls:4.32%
cases:1.96%
controls:0.67%
—
—
cases:3.16%
controls:0.55%
cases:8.59%
controls:4.34%
cases:15.49%
controls:12.16%
101
755
817
8286
54
391
864
8650
18
61
900
8980
—
29
50
889
8981
77
385
819
8483
130
1005
709
7259
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
1.2e+00
1.1e+00
—
—
—
2.2e+00
1.4e+00
cases:1.20%
controls:0.37%
cases:0.65%
controls:0.21%
—
—
—
—
—
—
cases:1.12%
controls:0.12%
cases:1.91%
controls:0.50%
11
33
907
9008
6
19
912
9022
—
—
—
10
11
886
8857
16
41
823
8223
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
1.2e+00
8.8e-01
—
1.0e+50
—
1.5e+00
8.1e-01
cases:2.29%
controls:0.69%
cases:1.09%
controls:0.45%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.67%
controls:0.37%
cases:4.05%
controls:1.85%
21
62
897
8979
10
41
908
9000
—
6
0
912
9041
—
15
33
881
8835
34
153
805
8111
triamcinolone and antiseptics
D07BB03 [21602150]
5.7e-01
1.1e+00
2.4e+00
—
1.5e+00
8.9e-01
3.6e-01
cases:3.38%
controls:1.95%
cases:1.53%
controls:0.52%
cases:0.76%
controls:0.07%
—
—
cases:0.54%
controls:0.12%
cases:1.34%
controls:0.55%
cases:2.50%
controls:1.77%
31
176
887
8865
14
47
904
8994
7
6
911
9035
—
5
11
913
9020
12
49
884
8819
21
146
818
8118
Rheumatoid/seropositive arthritis
L88 [2002000707]
1.6e+00
—
—
—
—
—
2.0e+00
cases:1.09%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.79%
controls:0.25%
10
21
908
9020
—
—
—
—
—
15
21
824
8243
carbamide
D02AE01 [21601975]
6.6e-01
1.6e+00
—
—
—
1.9e+00
1.5e+00
cases:0.98%
controls:0.51%
cases:0.76%
controls:0.15%
—
—
—
—
—
—
cases:1.00%
controls:0.15%
cases:1.07%
controls:0.23%
9
46
909
8995
7
14
911
9027
—
—
—
9
13
887
8855
9
19
830
8245
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.2e-01
4.6e-01
8.7e-01
—
1.0e+00
4.9e-01
3.0e-01
cases:27.02%
controls:21.14%
cases:16.45%
controls:11.07%
cases:4.79%
controls:2.07%
—
—
cases:5.66%
controls:2.09%
cases:17.52%
controls:11.50%
cases:35.16%
controls:28.61%
248
1911
670
7130
151
1001
767
8040
44
187
874
8854
—
52
189
866
8842
157
1020
739
7848
295
2364
544
5900
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
6.0e-01
—
—
—
—
1.8e+00
1.5e+00
cases:1.20%
controls:0.66%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.15%
cases:2.50%
controls:0.56%
11
60
907
8981
—
—
—
—
8
13
888
8855
21
46
818
8218
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
5.5e-01
6.7e-01
—
—
2.4e+00
8.5e-01
8.9e-01
cases:4.03%
controls:2.37%
cases:1.63%
controls:0.84%
—
—
—
—
cases:0.87%
controls:0.08%
cases:1.90%
controls:0.82%
cases:7.39%
controls:3.16%
37
214
881
8827
15
76
903
8965
—
—
8
7
910
9024
17
73
879
8795
62
261
777
8003
alendronic acid; oral
M05BA04 [21604152]
1.0e+00
8.3e-01
—
—
—
1.1e+00
1.2e+00
cases:2.18%
controls:0.77%
cases:1.31%
controls:0.58%
—
—
—
—
—
—
cases:1.67%
controls:0.58%
cases:3.34%
controls:1.04%
20
70
898
8971
12
52
906
8989
—
—
—
15
51
881
8817
28
86
811
8178
ibuprofen
R02AX02 [1588667]
1.2e-01
4.7e-01
1.2e+00
—
1.6e+00
2.4e-01
2.1e-01
cases:30.07%
controls:27.64%
cases:18.85%
controls:12.70%
cases:5.01%
controls:1.49%
—
—
cases:7.73%
controls:1.67%
cases:16.29%
controls:13.29%
cases:37.90%
controls:33.00%
276
2499
642
6542
173
1148
745
7893
46
135
872
8906
—
71
151
847
8880
146
1179
750
7689
318
2727
521
5537
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.2e-01
4.7e-01
1.2e+00
—
1.6e+00
2.4e-01
2.1e-01
cases:30.07%
controls:27.64%
cases:18.85%
controls:12.70%
cases:5.01%
controls:1.49%
—
—
cases:7.73%
controls:1.67%
cases:16.29%
controls:13.29%
cases:37.90%
controls:33.00%
276
2499
642
6542
173
1148
745
7893
46
135
872
8906
—
71
151
847
8880
146
1179
750
7689
318
2727
521
5537
hydroxyzine; oral, parenteral
N05BB01 [21604590]
6.1e-01
6.1e-01
1.8e+00
—
2.3e+00
6.5e-01
9.7e-01
cases:2.94%
controls:1.63%
cases:0.87%
controls:0.48%
cases:0.54%
controls:0.09%
—
—
cases:0.65%
controls:0.07%
cases:1.12%
controls:0.59%
cases:3.58%
controls:1.39%
27
147
891
8894
8
43
910
8998
5
8
913
9033
—
6
6
912
9025
10
52
886
8816
30
115
809
8149
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
5.4e-01
1.2e+00
—
—
—
1.4e+00
6.3e-01
cases:4.79%
controls:2.85%
cases:2.72%
controls:0.82%
—
—
—
—
—
—
cases:2.90%
controls:0.73%
cases:5.24%
controls:2.86%
44
258
874
8783
25
74
893
8967
—
—
—
26
65
870
8803
44
236
795
8028
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
7.8e-01
—
—
—
—
1.7e+00
1.6e+00
cases:1.42%
controls:0.65%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.17%
cases:2.74%
controls:0.58%
13
59
905
8982
—
—
—
—
8
15
888
8853
23
48
816
8216
Cathetrisation of vein
TPH04 [2001309597]
9.6e-01
1.2e+00
2.0e+00
—
—
8.9e-01
1.1e+00
cases:3.92%
controls:1.54%
cases:1.53%
controls:0.46%
cases:0.54%
controls:0.08%
—
—
—
—
cases:1.34%
controls:0.55%
cases:5.36%
controls:1.91%
36
139
882
8902
14
42
904
8999
5
7
913
9034
—
—
12
49
884
8819
45
158
794
8106
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
1.7e-01
1.2e+00
1.6e+00
—
2.0e+00
3.9e-01
4.5e-01
cases:2.29%
controls:1.94%
cases:2.40%
controls:0.76%
cases:0.54%
controls:0.11%
—
—
cases:1.09%
controls:0.14%
cases:1.34%
controls:0.91%
cases:4.29%
controls:2.78%
21
175
897
8866
22
69
896
8972
5
10
913
9031
—
10
13
908
9018
12
81
884
8787
36
230
803
8034
naproxcinod
M01AE18 [40254094]
1.2e-01
1.7e-01
1.7e+00
—
1.5e+00
3.2e-01
3.0e-02
cases:10.57%
controls:9.52%
cases:3.59%
controls:3.06%
cases:1.74%
controls:0.33%
—
—
cases:1.85%
controls:0.42%
cases:4.24%
controls:3.12%
cases:9.54%
controls:9.28%
97
861
821
8180
33
277
885
8764
16
30
902
9011
—
17
38
901
8993
38
277
858
8591
80
767
759
7497
naproxen; oral, rectal
M01AE02 [21603968]
1.2e-01
1.7e-01
1.7e+00
—
1.5e+00
3.2e-01
3.0e-02
cases:10.57%
controls:9.52%
cases:3.59%
controls:3.06%
cases:1.74%
controls:0.33%
—
—
cases:1.85%
controls:0.42%
cases:4.24%
controls:3.12%
cases:9.54%
controls:9.28%
97
861
821
8180
33
277
885
8764
16
30
902
9011
—
17
38
901
8993
38
277
858
8591
80
767
759
7497
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
1.1e+00
1.3e+00
—
—
—
2.0e+00
1.1e+00
cases:1.42%
controls:0.50%
cases:0.54%
controls:0.15%
—
—
—
—
—
—
cases:0.78%
controls:0.10%
cases:1.79%
controls:0.59%
13
45
905
8996
5
14
913
9027
—
—
—
7
9
889
8859
15
49
824
8215
Crohn disease [regional enteritis]
K50 [45755435]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.06%
—
—
—
—
—
—
11
5
828
8259
Removal of sutures
SPAT1153 [2001700254]
3.7e-01
3.6e-01
—
—
3.1e+00
4.9e-01
3.8e-01
cases:4.25%
controls:2.98%
cases:1.20%
controls:0.84%
—
—
—
—
cases:1.20%
controls:0.06%
cases:1.45%
controls:0.89%
cases:4.17%
controls:2.88%
39
269
879
8772
11
76
907
8965
—
—
11
5
907
9026
13
79
883
8789
35
238
804
8026
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
9.4e-01
5.9e-01
—
—
—
1.3e+00
8.9e-01
cases:3.27%
controls:1.31%
cases:1.09%
controls:0.61%
—
—
—
—
—
—
cases:1.56%
controls:0.45%
cases:4.05%
controls:1.71%
30
118
888
8923
10
55
908
8986
—
—
—
14
40
882
8828
34
141
805
8123
Extensive body CT
JN4BD [2001310899]
8.5e-01
—
—
—
—
1.4e+00
1.6e+00
cases:1.74%
controls:0.75%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.27%
cases:1.79%
controls:0.35%
16
68
902
8973
—
—
—
—
10
24
886
8844
15
29
824
8235
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.0e+00
1.4e+00
—
—
—
2.0e+00
1.0e+00
cases:1.42%
controls:0.52%
cases:0.54%
controls:0.13%
—
—
—
—
—
—
cases:1.23%
controls:0.17%
cases:1.67%
controls:0.61%
13
47
905
8994
5
12
913
9029
—
—
—
11
15
885
8853
14
50
825
8214
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
3.5e-01
6.2e-01
—
—
1.8e+00
1.2e+00
5.3e-01
cases:2.40%
controls:1.70%
cases:1.42%
controls:0.76%
—
—
—
—
cases:0.76%
controls:0.12%
cases:2.01%
controls:0.64%
cases:4.41%
controls:2.64%
22
154
896
8887
13
69
905
8972
—
—
7
11
911
9020
18
57
878
8811
37
218
802
8046
Intravenous administration of medicine
SPAT1255 [2001700356]
1.5e+00
1.7e+00
—
—
—
1.8e+00
1.5e+00
cases:1.42%
controls:0.32%
cases:0.65%
controls:0.12%
—
—
—
—
—
—
cases:0.67%
controls:0.11%
cases:1.55%
controls:0.35%
13
29
905
9012
6
11
912
9030
—
—
—
6
10
890
8858
13
29
826
8235
infliximab; parenteral
L04AB02 [21603909]
3.0e+00
—
—
—
—
—
—
cases:1.09%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
10
5
908
9036
—
—
—
—
—
—
Urology
34 [38004474]
4.0e-01
7.2e-01
2.3e+00
—
9.5e-01
5.6e-01
6.2e-01
cases:3.38%
controls:2.29%
cases:2.40%
controls:1.18%
cases:0.87%
controls:0.09%
—
—
cases:0.54%
controls:0.21%
cases:2.12%
controls:1.22%
cases:5.13%
controls:2.82%
31
207
887
8834
22
107
896
8934
8
8
910
9033
—
5
19
913
9012
19
108
877
8760
43
233
796
8031
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
89640-7 [1175715]
1.1e+00
2.9e+00
1.0e+50
—
1.0e+50
—
1.2e+00
cases:0.54%
controls:0.19%
cases:0.98%
controls:0.06%
cases:0.98%
controls:0.00%
—
—
cases:1.31%
controls:0.00%
—
—
cases:0.72%
controls:0.22%
5
17
913
9024
9
5
909
9036
9
0
909
9041
—
12
0
906
9031
—
6
18
833
8246

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
209
268
9.26
157.46
2.9
2.3
11.98
11.97
mg/l
0.01
197
255
138
342
4.44
51.36
1.5
1.2
—
—
—
0
0
311
1557
2.35
33.70
1.5
1.3
571.67
527.04
titre
0.17
72
341
297
1492
2.32
31.69
4.3
2.4
135.20
119.98
ug/g
0.36
252
1174
747
5437
2.02
28.68
11.8
6.0
0.57
0.56
e9/l
0.93
680
4702
765
5630
2.02
28.27
12.1
6.3
0.18
0.18
e9/l
0.08
696
4933
746
5444
2.00
28.21
11.8
6.1
0.04
0.04
e9/l
0.00
678
4705
754
5556
1.99
27.32
11.9
6.1
1.89
1.91
e9/l
0.13
694
4922
99
302
3.49
27.17
2.1
1.7
0.24
0.24
g/l
0.03
94
288
101
317
3.39
26.51
1.9
1.6
1.22
1.21
g/l
0.13
96
299
532
3529
1.92
25.92
11.4
5.9
—
—
—
0
0
431
2674
1.96
25.55
5.4
4.1
—
—
—
0
0
803
6141
1.96
24.93
14.4
9.3
4.24
4.06
e9/l
1.56
739
5353
72
188
4.01
24.74
1.3
1.3
266.37
242.06
u/ml
0.28
46
110
125
464
2.89
24.64
1.3
1.2
—
—
—
0
0
76
208
3.84
24.46
1.8
2.0
4.51
5.03
mmol/24h
0.76
69
185
36
51
7.25
24.26
1.2
1.1
175.59
186.54
iu/ml
0.09
36
51
684
5013
1.87
23.62
12.3
6.2
8.50
8.63
%
0.55
652
4708
102
358
3.02
22.19
1.5
1.2
—
—
—
0
0
677
5004
1.83
22.14
12.3
6.1
2.66
2.76
%
0.53
645
4691
63
162
4.05
22.10
1.2
1.2
—
—
—
0
0
682
5055
1.83
22.07
11.8
6.0
58.74
57.08
%
2.95
658
4833
118
451
2.80
21.98
1.9
1.7
3.98
7.26
iu/ml
1.36
27
104
638
4646
1.81
21.78
7.1
4.7
35.51
36.01
g/l
1.50
609
4385
674
4996
1.81
21.62
12.4
6.2
0.67
0.69
%
0.38
641
4674
688
5135
1.81
21.53
12.2
6.1
27.10
28.26
%
1.94
660
4879
698
5234
1.81
21.48
9.6
6.7
1.22
1.22
mmol/l
0.13
608
4531
635
4662
1.78
20.66
8.3
6.1
1.21
1.22
mmol/l
0.41
599
4304
27
35
7.87
19.60
1.3
1.0
—
—
—
0
0
171
832
2.23
18.92
4.1
2.8
10.73
10.45
g/l
0.33
160
767
394
2564
1.80
18.91
3.3
2.5
327.18
328.08
umol/l
0.06
353
2274
203
1065
2.09
18.53
2.5
2.1
346.58
382.33
nmol/l
1.75
192
992
377
2440
1.80
18.32
2.1
1.7
1.14
1.08
mg/l
0.15
295
1883
463
3195
1.74
17.93
5.5
4.0
7.40
7.40
ph
0.87
349
2294
943
7977
1.90
17.29
12.8
7.8
78.27
78.15
u/l
0.04
909
7576
468
3290
1.70
16.61
4.2
3.2
83.19
81.85
e6/l
0.01
368
2491
722
5719
1.67
15.97
5.2
3.9
0.00
4.01
estimate
1.07
177
1227
215
1213
1.94
15.84
2.0
1.6
—
—
—
0
0
222
1270
1.92
15.69
1.7
1.5
—
—
—
0
0
715
5666
1.66
15.63
5.2
3.9
0.00
0.00
estimate
0.50
173
1196
349
2298
1.74
15.52
3.2
2.6
6.04
7.04
e6/l
0.74
317
2107
247
1480
1.85
15.06
3.3
2.4
19.65
22.29
%
3.04
228
1386
721
5769
1.64
14.77
5.2
4.0
0.00
0.26
estimate
0.51
175
1159
278
1737
1.79
14.73
3.4
2.4
11.56
12.98
umol/l
3.31
264
1616
39
95
4.21
14.73
1.8
1.4
—
—
—
0
0
694
5513
1.63
14.53
8.0
6.1
10.01
11.09
umol/l
3.15
674
5261
158
823
2.06
14.52
3.2
2.6
74.18
72.76
e9/l
0.14
113
591
651
5095
1.62
14.45
3.3
2.5
76.91
77.60
nmol/l
0.26
612
4636
194
1090
1.93
14.38
4.1
2.5
1.89
1.87
%
0.11
179
972
101
440
2.42
14.34
1.3
1.3
0.24
1.15
u/ml
0.79
15
29
44
121
3.74
14.10
1.2
1.2
—
—
—
0
0
836
6985
1.67
14.06
6.2
4.7
317.50
1658.61
e6/l
—
8
100
404
2826
1.65
14.06
3.9
3.1
0.27
0.42
e6/l
1.77
305
2056
519
3867
1.61
13.96
5.1
3.8
61.46
87.93
e6/l
1.01
386
2660
133
659
2.15
13.92
2.2
1.8
1.01
1.40
g/l
2.54
123
609
368
2519
1.67
13.90
8.1
4.6
—
—
—
0
0
38
97
4.01
13.50
1.7
1.4
7.32
6.90
g/l
0.16
27
73
38
97
4.01
13.50
1.7
1.4
0.36
0.36
g/l
0.03
27
73
38
97
4.01
13.50
1.7
1.4
2.70
2.84
g/l
0.17
27
71
399
2811
1.63
13.35
3.1
2.2
3.24
2.82
mg/l
2.21
352
2421
167
915
1.96
13.28
7.1
4.1
0.47
0.71
%
1.18
66
252
387
2717
1.63
13.08
3.7
3.0
—
0.00
estimate
—
0
8
152
811
2.00
13.03
3.0
3.0
67.33
67.00
g/l
0.23
143
748
80
327
2.55
13.01
1.3
1.2
2.38
2.44
u/ml
—
8
32
605
4726
1.57
12.98
17.5
11.0
0.00
0.00
e9/l
0.18
518
3893
256
1615
1.75
12.94
3.3
2.4
2.36
2.35
g/l
0.18
236
1494
134
685
2.08
12.91
2.6
2.6
—
—
—
0
0
324
2185
1.67
12.79
2.1
2.0
—
—
—
0
0
171
957
1.92
12.75
7.5
4.3
0.96
1.04
%
0.16
68
269
79
328
2.51
12.45
1.3
1.2
4.07
10.63
u/ml
0.84
11
55
340
2348
1.63
12.11
1.9
1.5
2.66
2.30
g/l
1.50
217
1453
428
3124
1.58
12.09
5.7
4.0
0.02
0.00
estimate
0.34
171
1142
581
4564
1.54
11.70
4.5
3.5
6.21
6.25
ph
0.33
313
2591
579
4545
1.54
11.70
15.6
13.2
1.23
1.21
inr
0.44
471
3772
160
912
1.87
11.23
7.5
4.4
0.12
0.13
%
0.05
57
225
279
1874
1.64
10.96
1.8
1.7
—
—
—
0
0
227
1461
1.69
10.47
2.2
1.9
—
—
—
0
0
48
170
2.90
10.32
1.8
1.7
0.73
0.77
g/l
0.07
35
139
159
936
1.81
10.03
8.2
4.6
0.59
0.16
%
0.46
56
212
28
72
3.96
9.89
2.1
1.9
38.18
39.89
%
0.22
28
72
214
1376
1.68
9.87
3.7
3.2
4.36
5.11
e9/l
0.82
188
1220
192
1201
1.71
9.80
1.6
1.3
—
—
—
0
0
391
2906
1.52
9.71
4.2
3.1
1870.19
1108.11
ng/l
0.68
332
2463
70
309
2.35
9.68
3.1
4.1
42.26
62.64
mg/l
0.51
64
263
70
309
2.35
9.68
3.0
4.1
54.43
49.43
mg/l
0.09
64
263
85
410
2.16
9.52
1.9
1.9
1.50
1.53
g/l
0.09
76
364
283
1972
1.57
9.37
3.5
2.8
521.07
512.83
mosm/kgh2o
0.26
244
1745
26
66
4.01
9.35
2.2
2.1
73.69
73.02
%
0.06
26
61
452
3487
1.48
9.25
3.7
3.1
—
—
—
0
0
291
2047
1.56
9.23
1.4
1.3
6.95
11.11
u/ml
0.60
112
774
569
4604
1.45
9.03
2.3
2.1
94.98
97.24
pmol/l
0.52
320
2387
129
735
1.85
9.02
2.6
2.4
25.46
20.26
au/ml
0.29
14
74
654
5444
1.45
8.87
4.1
3.0
113.34
97.99
ug/l
0.97
627
5097
203
1324
1.64
8.80
8.8
5.0
1.04
1.03
mmol/l
0.28
190
1228
119
668
1.87
8.72
1.4
1.3
48.20
38.92
au/ml
—
5
53
713
6073
1.44
8.28
6.1
4.8
6.76
6.57
mmol/l
1.34
679
5724
108
598
1.89
8.26
1.3
1.2
—
—
—
0
0
143
864
1.75
8.22
1.5
1.4
—
—
—
0
0
39
141
2.83
8.13
1.7
1.4
—
—
—
0
0
39
141
2.83
8.13
1.7
1.4
—
—
—
0
0
39
141
2.83
8.13
1.7
1.4
—
—
—
0
0
39
141
2.83
8.13
1.7
1.4
—
—
—
0
0
244
1693
1.56
8.11
1.9
1.7
1220.94
1202.69
nmol/l
0.11
203
1269
128
754
1.78
8.02
1.6
1.3
199.87
207.57
u/ml
0.04
119
694
301
2191
1.50
8.00
1.4
1.3
38.01
32.02
iu/ml
0.26
96
672
47
189
2.55
7.98
4.3
3.9
4.26
4.20
e9/l
0.08
47
189
1092
10225
1.89
7.90
26.7
14.7
23.92
22.15
mg/l
1.05
978
8396
18
39
4.67
7.89
4.2
2.8
35.20
241.76
ug/l
0.45
18
32
427
3337
1.44
7.85
3.0
2.5
64.89
61.73
u/l
0.19
405
3085
533
4339
1.42
7.79
5.2
3.8
0.00
0.04
estimate
3.63
143
998
19
30
6.42
7.72
2.8
2.9
150.75
39.33
au/ml
—
6
6
477
3824
1.41
7.53
4.6
3.6
31.04
58.31
ng/l
0.80
332
2559
244
1719
1.53
7.53
3.5
2.8
0.99
1.10
e6/l
0.25
131
873
155
981
1.67
7.51
2.7
2.2
0.22
0.21
g/l
0.29
140
915
244
1722
1.53
7.46
4.9
3.2
0.82
0.82
mmol/l
0.20
234
1632
60
279
2.21
7.40
3.2
3.9
1.47
3.43
ratio
0.84
40
159
293
2167
1.47
7.09
1.9
1.7
426.58
33407276.05
pmol/l
2.39
249
1814
469
3783
1.40
7.01
3.5
3.4
2.36
2.36
mmol/l
0.32
427
3456
219
1532
1.53
6.94
2.7
2.0
29.55
29.18
s
0.37
212
1482
355
2736
1.43
6.86
1.4
1.3
1.85
1.69
u/ml
0.07
93
756
65
325
2.06
6.69
3.4
3.1
229.89
305.26
mg/l
0.52
36
126
52
239
2.23
6.62
4.7
3.6
60.71
58.61
%
0.63
52
239
26
84
3.14
6.61
1.0
1.1
15.85
14.42
u/ml
—
6
42
21
59
3.61
6.61
2.2
2.1
447.73
501.32
e6/l
0.21
15
47
43
182
2.41
6.60
1.6
1.3
125.13
161.97
au/ml
—
8
51
437
3516
1.39
6.50
4.0
3.3
7.16
7.28
mmol/l
0.22
371
3002
193
1342
1.52
6.26
7.5
6.2
104.51
104.29
mmol/l
0.30
193
1342
130
826
1.64
6.19
8.9
7.5
—
—
—
0
0
1093
10353
1.74
5.98
26.0
17.2
3.94
3.95
mmol/l
0.27
1075
10133
130
834
1.63
5.96
3.2
2.3
0.26
0.45
e6/l
0.68
124
793
17
34
5.06
5.88
2.1
1.8
35.59
28.38
%
1.14
17
34
217
1566
1.47
5.85
3.8
3.0
5.89
3.55
e6/l
1.24
104
722
26
91
2.90
5.80
1.3
1.1
111.31
111.67
pmol/l
0.01
26
91
1091
10341
1.71
5.79
25.7
17.0
139.60
139.64
mmol/l
0.26
1074
10144
178
1238
1.52
5.75
3.9
2.5
6.24
7.41
umol/l
0.56
153
1072
44
202
2.22
5.65
1.5
1.3
—
—
—
0
0
141
935
1.58
5.64
6.4
3.7
7.35
7.36
ph
0.06
116
670
16
32
5.05
5.57
2.0
1.3
—
—
—
0
0
71
395
1.85
5.41
2.8
1.8
21.03
20.58
s
0.51
65
353
376
3024
1.36
5.40
1.8
1.7
18.84
21.03
nmol/l
2.27
328
2572
440
3633
1.34
5.28
3.9
3.1
29.49
30.00
u/l
0.16
414
3438
330
2612
1.37
5.22
5.8
3.8
93.32
92.73
%
0.15
323
2553
96
590
1.68
5.21
4.8
3.7
7.42
7.42
ph
0.59
85
486
20
64
3.16
5.20
1.1
1.0
—
—
—
0
0
922
8502
1.38
5.01
5.4
4.7
14.68
14.68
pmol/l
0.01
852
7872
130
870
1.56
5.00
5.0
4.0
—
—
—
0
0
73
421
1.78
4.97
4.8
3.8
—
—
—
0
0
396
3242
1.33
4.97
4.3
3.4
35.31
39.92
mg/l
0.27
251
2007
403
3309
1.33
4.95
5.1
4.1
7.28
8.04
mg/mmol
0.13
253
2003
140
958
1.52
4.87
5.4
3.4
2.00
2.01
mmol/l
0.01
124
831
23
84
2.77
4.79
1.3
1.2
—
—
—
0
0
50
258
1.98
4.79
1.3
1.2
—
—
—
0
0
43
210
2.09
4.78
1.9
1.7
—
—
—
0
0
176
1269
1.45
4.74
1.7
1.4
—
—
—
0
0
56
302
1.90
4.73
1.3
1.2
260.00
92.90
titre
—
7
31
155
1093
1.48
4.67
7.3
7.6
1.09
1.05
mmol/l
0.05
138
906
393
3237
1.32
4.67
10.0
6.1
—
—
—
0
0
112
739
1.57
4.59
2.9
3.7
4.52
4.53
pmol/l
0.04
106
658
28
116
2.45
4.57
1.8
2.8
—
—
—
0
0
48
249
1.97
4.55
1.7
1.6
13064.30
12666.40
e6/l
0.03
40
176
126
856
1.53
4.54
4.9
3.4
84.45
81.28
ng/l
0.16
113
740
17
54
3.18
4.49
1.1
1.0
—
—
—
0
0
145
1017
1.49
4.49
2.5
2.1
0.00
0.02
estimate
0.78
25
224
25
101
2.51
4.31
1.4
1.1
—
—
—
0
0
384
3186
1.30
4.25
4.5
3.3
0.01
0.10
estimate
0.94
148
983
144
1020
1.47
4.25
2.4
2.3
35.37
38.21
u/l
0.15
114
847
23
90
2.59
4.23
1.3
1.2
—
—
—
0
0
124
853
1.51
4.22
4.6
3.7
1.22
1.23
mmol/l
0.62
109
727
55
307
1.83
4.20
16.1
9.6
—
—
—
0
0
141
997
1.47
4.20
5.5
3.4
5.91
5.82
kpa
0.57
134
969
25
103
2.46
4.15
1.3
1.3
—
—
—
0
0
140
993
1.46
4.10
5.6
3.5
7.37
7.38
ph
0.66
85
568
271
2153
1.34
4.07
2.7
2.7
2.45
2.45
mmol/l
0.06
252
1945
50
274
1.86
4.06
4.4
3.3
2.50
2.43
index
0.03
24
147
311
2525
1.31
4.00
5.4
4.0
1.02
1.61
kg/l
0.50
211
1691
500
4319
1.27
3.98
2.4
2.1
—
—
—
0
0
406
3418
1.29
3.97
3.9
2.2
—
—
—
0
0
81
514
1.62
3.94
2.9
2.1
0.15
1.43
estimate
0.43
20
175
198
1506
1.38
3.93
1.3
1.2
—
—
—
0
0
25
106
2.39
3.92
1.1
1.1
—
—
—
0
0
25
106
2.39
3.92
2.0
2.8
0.86
1.08
g/24h
0.33
11
64
1118
10791
1.67
3.90
30.3
19.0
75.11
72.40
umol/l
1.80
1105
10674
152
1106
1.43
3.90
7.4
7.7
7.43
7.42
ph
1.61
83
638
10
19
5.30
3.83
1.3
1.2
—
—
—
0
0
1112
10724
1.62
3.82
18.4
11.6
24.75
24.88
u/l
0.11
1081
10443
34
167
2.07
3.78
1.2
1.0
—
—
—
0
0
31
147
2.14
3.77
1.3
1.2
—
73.85
—
0
8
26
115
2.29
3.73
2.5
2.2
—
—
—
0
0
12
29
4.17
3.71
1.8
1.4
—
—
—
0
0
10
20
5.03
3.69
1.0
1.0
—
—
—
0
0
377
3171
1.28
3.66
2.5
2.1
112.72
193.38
u/l
3.25
361
3032
32
159
2.04
3.47
1.1
1.2
—
—
—
0
0
776
7126
1.26
3.45
4.5
3.9
—
6313.81
—
0
16
122
875
1.44
3.40
1.3
1.2
196.93
143.85
u/ml
0.65
52
351
1024
9765
1.36
3.27
6.7
5.8
1.91
1.88
mu/l
0.35
965
9142
122
883
1.43
3.24
1.5
1.4
—
—
—
0
0
8
16
5.03
3.05
1.0
1.1
—
—
—
0
0
33
176
1.90
2.98
1.4
1.2
2.63
4.72
u/ml
0.75
19
72
18
75
2.42
2.98
1.3
1.1
—
—
—
0
0
24
115
2.11
2.90
2.0
1.7
65.18
59.70
%
0.32
17
77
24
116
2.09
2.84
1.2
1.3
—
—
—
0
0
125
932
1.38
2.82
7.1
8.1
117.75
120.36
g/l
0.82
125
912
165
1285
1.33
2.81
1.7
1.5
—
—
—
0
0
124
925
1.38
2.79
1.2
1.2
—
—
—
0
0
50
309
1.65
2.77
2.2
2.5
—
—
—
0
0
31
167
1.88
2.73
1.2
1.1
—
—
—
0
0
31
168
1.87
2.69
1.0
1.1
3.20
1.90
eliau/ml
0.66
11
81
34
191
1.80
2.64
1.0
1.1
4.17
16.49
au/ml
—
7
58
10
30
3.35
2.60
1.2
1.3
29.40
28.73
s
—
10
30
10
30
3.35
2.60
1.3
1.3
—
—
—
0
0
41
245
1.70
2.59
1.3
1.5
2380.26
187.37
e6/l
0.65
35
187
41
245
1.70
2.59
1.2
1.5
329.29
7.83
e6/l
0.67
34
179
7
16
4.39
2.47
1.4
1.3
—
—
—
0
0
24
123
1.97
2.46
2.3
2.7
—
38.81
—
0
14
112
841
1.37
2.44
5.1
3.0
4.36
4.47
kpa
0.22
106
815
550
4980
1.20
2.41
3.9
2.7
—
—
estimate
—
0
0
6
12
5.02
2.40
1.0
2.8
0.50
0.67
u/field
—
6
12
17
77
2.23
2.38
1.4
1.4
—
—
—
0
0
916
8703
1.23
2.36
28.9
18.5
13.90
13.57
%
9.19
905
8597
8
22
3.65
2.36
6.8
2.7
—
—
—
0
0
232
1937
1.25
2.30
4.4
3.7
533.85
344.78
ng/l
0.28
174
1406
13
53
2.47
2.28
2.8
1.4
9.33
6.48
ug/l
0.33
13
45
98
729
1.38
2.28
2.9
3.0
208.84
185.16
ng/l
0.18
83
670
16
73
2.21
2.21
1.4
1.3
3426.25
146136.08
e6/l
—
8
36
74
527
1.43
2.21
9.8
9.5
15.51
15.77
%
0.45
74
507
5
10
5.02
2.07
1.2
1.0
50.34
95.26
ng/l
—
5
5
7
20
3.51
2.05
2.1
1.7
—
—
—
0
0
23
125
1.86
2.03
2.3
1.6
46.45
25.15
ng/l
0.42
23
125
11
44
2.51
2.01
1.7
1.7
—
—
—
0
0
98
745
1.34
2.01
3.5
2.3
4.75
6.59
ug/l
0.94
78
665
22
388
0.56
2.00
1.2
1.1
0.73
0.63
ratio
—
5
54
25
422
0.58
1.95
1.2
1.1
1.45
1.58
g/l
2.24
25
422
59
414
1.45
1.94
1.6
1.6
15.91
9.27
u/ml
—
8
87
1085
10569
1.32
1.91
20.0
13.3
—
—
—
0
0
9
34
2.66
1.86
1.9
2.8
0.56
0.62
mmol/l
—
9
34
1134
11129
1.47
1.86
36.7
22.7
90.74
90.90
fl
0.51
1123
11024
384
3431
1.18
1.85
4.1
3.4
—
0.80
—
0
10
17
86
1.99
1.85
1.5
1.3
2174.45
1992.60
e6/l
0.05
11
57
1134
11130
1.46
1.85
36.8
22.8
4.42
4.45
e12/l
1.49
1116
10892
1134
11130
1.46
1.85
36.7
22.7
29.99
30.22
pg
3.85
1123
11024
1134
11130
1.46
1.85
37.5
23.1
39.69
40.01
%
1.54
1122
11019
6
17
3.54
1.84
2.3
1.2
—
—
—
0
0
1134
11132
1.46
1.82
36.9
22.8
6.87
6.67
e9/l
2.27
1116
10885
47
320
1.49
1.81
1.2
1.2
—
—
—
0
0
1134
11135
1.45
1.78
37.2
22.9
131.36
133.65
g/l
6.14
1123
11029
1133
11124
1.45
1.78
36.9
22.8
263.70
257.18
e9/l
2.38
1117
10912
18
95
1.91
1.76
26.5
7.9
6.79
6.99
mmol/l
0.14
13
74
21
117
1.81
1.75
1.0
1.1
—
—
—
0
0
6
18
3.34
1.75
1.3
1.3
—
—
—
0
0
32
203
1.59
1.69
3.6
3.4
—
—
—
0
0
20
111
1.82
1.69
1.2
1.6
—
—
—
0
0
31
196
1.60
1.67
1.1
1.1
0.19
0.79
u/ml
2.29
18
78
35
228
1.55
1.66
1.6
1.8
—
—
—
0
0
34
220
1.56
1.66
1.1
1.5
—
—
—
0
0
23
135
1.72
1.63
7.4
5.3
12.84
12.12
mg/l
0.29
23
124
25
151
1.67
1.60
1.2
1.2
—
—
—
0
0
6
20
3.01
1.58
2.3
1.7
—
—
—
0
0
56
407
1.39
1.56
1.3
1.3
182.84
231.38
miu/ml
0.43
24
191
16
85
1.89
1.55
3.1
2.7
—
—
—
0
0
66
494
1.36
1.55
2.8
2.3
—
—
—
0
0
13
64
2.04
1.54
1.6
2.6
54.17
42.99
%
—
6
37
752
7131
1.15
1.53
3.8
3.2
43.57
43.89
u/l
0.05
708
6735
982
9505
1.20
1.53
7.2
6.1
39.97
38.88
mmol/mol
3.24
927
8947
99
1233
0.78
1.53
1.8
1.9
3.40
3.39
ratio
0.02
71
958
26
162
1.62
1.50
1.0
1.1
0.79
6.85
u/ml
2.68
16
67
31
202
1.55
1.49
1.1
1.1
4.35
3.30
u/ml
0.27
17
102
78
605
1.31
1.45
7.6
7.6
24.47
24.47
mmol/l
0.00
78
583
9
38
2.38
1.45
1.3
1.9
80.27
802.16
nmol/24h
—
9
38
11
52
2.13
1.44
1.1
1.7
—
—
—
0
0
5
16
3.13
1.44
1.2
1.1
—
—
—
0
0
6
22
2.74
1.43
1.0
1.5
—
—
—
0
0
60
450
1.35
1.41
1.1
1.1
—
—
—
0
0
29
433
0.66
1.40
1.2
1.2
0.90
0.88
g/l
0.15
29
433
45
322
1.41
1.40
1.4
1.4
260.60
283.92
ug/g
0.33
25
193
10
47
2.14
1.34
1.7
1.4
133.80
168.59
mmol/24h
—
10
47
28
184
1.53
1.32
1.5
1.4
—
—
—
0
0
39
276
1.43
1.30
1.4
1.2
—
—
—
0
0
86
691
1.26
1.25
1.5
1.3
24.98
27.40
iu/l
0.28
74
600
14
77
1.83
1.25
1.4
1.3
—
—
—
0
0
64
495
1.31
1.25
2.0
2.0
—
—
—
0
0
35
245
1.44
1.24
1.2
1.1
1.93
2.81
u/ml
0.31
20
132
36
254
1.43
1.23
1.2
1.3
3.63
3.73
mmol/l
0.17
36
236
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
16
93
1.73
1.21
1.0
1.1
—
—
—
0
0
14
78
1.80
1.21
1.3
1.4
—
—
—
0
0
159
1368
1.19
1.21
1.4
1.3
—
—
—
0
0
22
140
1.58
1.20
1.8
2.1
0.80
0.93
%
0.60
17
89
337
3071
1.14
1.19
1.5
1.5
—
—
—
0
0
29
198
1.48
1.17
1.1
1.1
0.22
1.96
u/ml
2.41
17
100
20
126
1.60
1.15
1.6
2.0
33.65
32.21
pg
0.64
20
126
27
185
1.47
1.09
4.1
3.5
0.76
0.86
nmol/l
0.78
21
152
15
89
1.69
1.08
1.2
1.1
—
—
—
0
0
20
129
1.56
1.06
4.7
3.0
—
—
—
0
0
32
229
1.41
1.04
1.8
1.7
47.84
43.04
nmol/l
0.20
32
220
11
60
1.84
1.03
1.0
1.1
0.06
1.00
u/ml
—
5
22
42
316
1.34
1.02
1.6
1.3
12.37
10.21
u/l
0.47
34
255
33
239
1.39
1.01
2.7
2.1
118.09
129.48
g/l
0.84
21
197
25
172
1.46
1.00
1.3
1.2
—
—
—
0
0
17
107
1.60
1.00
4.5
3.3
15.42
11.86
index
0.77
12
70
9
50
1.81
0.96
1.0
1.4
134.44
146.40
nmol/l
—
9
50
20
293
0.68
0.95
1.3
1.4
—
—
—
0
0
15
93
1.62
0.94
2.2
2.3
—
—
—
0
0
12
70
1.72
0.92
5.2
3.5
0.83
0.87
index
0.06
12
70
120
1035
1.18
0.92
3.8
4.1
35.36
19.50
ug/l
0.28
91
848
21
301
0.69
0.90
1.3
1.5
—
—
—
0
0
13
79
1.65
0.88
1.2
1.2
—
—
—
0
0
13
79
1.65
0.88
1.3
1.7
—
—
—
0
0
20
288
0.69
0.88
1.3
1.4
1.35
1.24
mm
0.26
14
208
28
203
1.39
0.88
3.4
3.5
2.98
2.63
mmol/l
0.21
19
137
23
161
1.44
0.87
1.7
1.4
0.54
11.66
nmol/l
0.50
23
154
25
178
1.41
0.86
1.0
1.1
0.50
4.21
u/ml
3.72
16
88
22
153
1.45
0.86
1.0
1.0
0.01
0.26
u/ml
—
10
49
21
145
1.46
0.85
1.7
1.4
0.19
0.32
nmol/l
0.41
16
105
6
31
1.94
0.84
1.0
1.2
—
—
—
0
0
45
356
1.27
0.81
2.0
2.1
4.79
18.89
iu/l
0.46
17
156
39
304
1.29
0.79
1.3
1.2
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
16
232
0.69
0.75
3.7
4.0
47.96
32.87
u/ml
0.26
16
227
11
67
1.65
0.75
2.0
1.6
100.35
104.67
ng/l
0.04
11
67
5
25
2.00
0.72
6.0
3.4
58.10
51.36
%
—
5
25
10
60
1.67
0.72
1.1
1.3
—
—
—
0
0
396
4187
0.92
0.70
3.2
3.1
—
—
—
0
0
80
929
0.85
0.70
1.6
1.7
3.57
3.45
mmol/l
0.34
51
656
11
70
1.58
0.65
1.2
1.2
—
—
—
0
0
16
112
1.43
0.63
1.1
1.5
—
—
—
0
0
167
1523
1.11
0.61
5.3
5.2
2.72
2.24
ug/l
0.38
148
1375
9
141
0.64
0.60
1.4
1.1
—
—
—
0
0
19
141
1.35
0.56
1.3
1.4
—
—
nmol/l
—
0
0
11
73
1.51
0.56
1.2
1.2
0.49
0.53
ratio
—
5
40
8
55
1.46
0.56
1.3
3.1
16.06
16.03
%
—
8
55
6
37
1.62
0.55
1.0
1.2
76.28
170.71
pmol/l
—
6
37
83
734
1.14
0.52
2.3
3.2
52.26
77.51
u/ml
0.41
78
709
11
75
1.47
0.50
1.3
1.5
12.33
11.51
umol/l
0.13
11
68
55
637
0.86
0.50
1.5
1.7
—
—
—
0
0
24
189
1.28
0.49
1.3
1.7
—
—
—
0
0
60
521
1.16
0.49
2.3
2.1
8715.82
5969.21
u/l
0.25
20
222
142
1308
1.10
0.46
2.0
1.7
—
—
—
0
0
10
69
1.45
0.44
1.6
1.3
86.40
75.45
umol/l
—
10
69
27
220
1.23
0.44
2.0
2.4
47.60
117.22
ug/min
0.96
14
133
53
461
1.16
0.44
4.6
5.9
1.50
1.57
%
0.33
53
438
48
415
1.16
0.43
4.8
6.3
0.81
0.90
%
0.98
48
390
5
31
1.62
0.43
2.8
1.8
40.56
41.36
g/l
—
5
31
8
57
1.41
0.42
1.0
1.1
2066.75
1642.21
miu/ml
—
8
57
91
1003
0.90
0.42
1.4
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
43
371
1.17
0.40
2.8
3.2
95.79
910.95
u/ml
1.39
34
323
59
665
0.88
0.40
1.5
1.6
903.91
990.95
mu/l
0.25
49
557
991
9793
1.07
0.39
5.6
4.9
5.96
5.86
mmol/l
1.59
922
9040
133
1234
1.09
0.38
1.7
1.7
—
—
—
0
0
49
431
1.14
0.37
1.3
1.5
—
—
—
0
0
52
461
1.13
0.35
1.3
1.5
—
—
—
0
0
9
124
0.72
0.35
2.0
2.3
—
—
—
0
0
85
778
1.10
0.34
1.2
1.3
—
—
—
0
0
24
200
1.20
0.34
1.4
1.4
45.44
61.31
mmol/l
2.14
16
166
52
463
1.13
0.33
1.3
1.5
—
—
—
0
0
42
371
1.14
0.31
2.1
1.8
—
—
—
0
0
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
7
99
0.71
0.30
1.0
1.6
—
—
—
0
0
8
65
1.23
0.27
1.9
2.9
7.75
8.42
mmol/l
—
8
65
5
38
1.32
0.23
1.6
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
208.80
—
0
5
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
7.3
—
10.42
—
0
12
0
12
0.00
0.21
0.0
3.7
—
41.92
—
0
12
50
460
1.09
0.21
1.3
1.5
—
—
—
0
0
100
1056
0.94
0.21
2.0
1.5
—
—
—
0
0
50
462
1.09
0.19
1.3
1.5
—
—
—
0
0
6
53
1.13
0.18
1.0
1.2
14.17
9.60
mm/h
—
6
53
1026
10201
1.04
0.18
6.0
5.6
2.69
2.76
mmol/l
1.57
965
9552
56
526
1.07
0.15
3.3
2.2
11.31
12.02
nmol/l
0.28
51
486
9
80
1.13
0.15
1.0
1.0
—
—
—
0
0
952
9571
0.97
0.13
4.5
4.1
1.31
1.26
mmol/l
1.25
884
8842
19
209
0.91
0.11
6.1
9.3
104.32
105.35
mmol/l
0.47
19
190
32
342
0.93
0.11
1.3
1.3
—
—
—
0
0
19
208
0.91
0.10
6.1
9.3
10.89
11.27
mmol/l
0.31
19
189
447
4420
1.02
0.10
2.1
1.9
1.39
1.33
mmol/l
0.81
368
3798
1000
10038
0.98
0.10
5.2
4.9
1.47
1.52
mmol/l
2.75
938
9379
23
213
1.08
0.09
1.0
1.1
—
—
—
0
0
23
213
1.08
0.09
1.0
1.1
—
—
—
0
0
6
57
1.05
0.08
1.3
1.2
33.52
32.61
nmol/l
—
6
49
872
8680
1.02
0.08
30.6
19.1
329.91
331.72
g/l
6.86
865
8625
8
75
1.07
0.07
1.3
1.2
42.25
35.84
mmol/l
—
8
70
8
77
1.04
0.07
15.4
13.1
0.56
0.63
mmol/l
—
8
69
1010
10073
1.02
0.06
5.3
5.0
4.63
4.72
mmol/l
2.28
947
9465
47
453
1.04
0.06
1.5
1.5
0.30
0.32
mg/l
0.10
18
186
31
296
1.05
0.06
5.0
7.9
1.14
1.31
mmol/l
1.01
31
260
25
237
1.06
0.05
4.8
4.4
—
—
—
0
0
21
221
0.95
0.04
1.7
1.4
0.21
0.38
nmol/l
2.00
14
186
88
864
1.02
0.04
2.8
2.5
6.15
6.07
ph
0.41
61
562
53
537
0.99
0.01
1.1
1.1
—
—
—
0
0
12
118
1.02
0.00
1.6
1.9
90.11
90.47
%
0.11
12
118
91
911
1.00
0.00
3.0
3.1
0.90
0.71
ug/l
0.79
55
565
0
7
0.00
0.00
0.0
1.1
—
17.11
—
0
7
8
82
0.98
0.00
1.4
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
376.43
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
172.33
—
0
6
0
6
0.00
-0.00
0.0
2.3
—
0.50
—
0
6
8
79
1.01
-0.00
3.0
1.8
9.63
6.69
mmol/l
—
8
54

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHEMANODOSUM and mortality.

Females

Parameter HR [95% CI] p-value
L12_ERYTHEMANODOSUM 1.225 [1.06, 1.41] 0.005
Birth year 0.99 [0.98, 1.0] 0.027

During the follow-up period (1.1.1998 — 31.12.2019), 380 out of 3301 females with L12_ERYTHEMANODOSUM died.

Males

Parameter HR [95% CI] p-value
L12_ERYTHEMANODOSUM 1.581 [1.26, 1.98] < 0.001
Birth year 0.984 [0.97, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 148 out of 1122 males with L12_ERYTHEMANODOSUM died.

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHEMANODOSUM.

N-year risk Females Males
1 0.106% 0.252%
5 0.531% 1.652%
10 1.452% 4.087%
15 2.738% 7.634%
20 5.092% 12.892%

Relationships between endpoints

↥

Index endpoint: L12_ERYTHEMANODOSUM – Erythema nodosum

GWS hits: 4

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data